id	sid	tid	token	lemma	pos
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	1	reflected	reflect	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	2	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	3	pulse	pulse	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	4	rate	rate	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	5	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	6	are	be	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	7	important	important	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	8	predictors	predictor	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	9	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	10	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	11	shift	shift	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	12	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	13	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	14	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	15	distribution	distribution	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	16	observed	observe	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	17	when	when	WRB
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	18	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	19	low	low	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	20	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	21	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	22	community	community	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	23	becomes	become	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	24	urbanised	urbanised	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	1	25	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	1	We	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	2	would	would	MD
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	3	suggest	suggest	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	4	that	that	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	5	these	these	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	6	same	same	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	7	factors	factor	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	8	may	may	MD
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	9	play	play	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	10	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	11	part	part	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	12	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	13	at	at	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	14	least	least	JJS
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	15	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	16	early	early	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	17	stages	stage	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	18	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	19	development	development	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	20	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	21	"	"	``
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	22	essential	essential	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	23	hypertension	hypertension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	24	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	2	25	"	"	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	3	1	This	this	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	3	2	project	project	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	3	3	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	3	4	supported	support	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	3	5	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	3	6	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	3	7	Wellcome	Wellcome	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	3	8	Trust	Trust	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	3	9	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	4	1	We	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	4	2	thank	thank	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	4	3	Clare	Clare	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	4	4	Poulter	Poulter	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	4	5	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	4	6	Jan	Jan	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	4	7	Lury	Lury	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	4	8	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	4	9	fieldwork	fieldwork	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	4	10	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	5	1	I	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	5	2	Kannel	kannel	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	5	3	W'B.	w'b.	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	6	1	Some	some	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	6	2	lessons	lesson	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	6	3	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	6	4	cardiovascular	cardiovascular	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	6	5	epidemiology	epidemiology	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	6	6	f'rom	f'rom	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	6	7	Framingham	Framingham	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	6	8	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	7	1	Am	Am	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	7	2	]	]	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	7	3	Cardiol	Cardiol	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	7	4	1976;37:269	1976;37:269	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	7	5	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	7	6	82	82	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	7	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	8	1	2	2	LS
work_dkfzaqe2ezbwvieo2gzsrnlssu	8	2	Working	Working	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	8	3	Group	Group	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	8	4	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	8	5	Arteriosclerosis	Arteriosclerosis	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	8	6	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	8	7	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	8	8	National	National	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	8	9	Heart	Heart	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	8	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	8	11	Lung	Lung	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	8	12	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	8	13	Blood	Blood	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	8	14	Institute	Institute	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	8	15	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	9	1	Report	report	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	9	2	ofthe	ofthe	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	9	3	wtorking	wtorke	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	9	4	group	group	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	9	5	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	9	6	artenrosclerosis	artenrosclerosis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	9	7	of'the	of'the	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	9	8	National	National	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	9	9	Heart	Heart	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	9	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	9	11	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	10	1	ung	ung	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	10	2	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	10	3	Blood	Blood	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	10	4	Institute	Institute	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	10	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	1	Bethesda	bethesda	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	2	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	3	United	United	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	4	States	States	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	5	Department	Department	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	6	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	7	Health	Health	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	8	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	9	Human	Human	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	10	Services	Services	NNPS
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	11	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	12	Public	Public	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	13	Health	Health	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	14	Service	Service	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	15	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	16	National	National	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	17	Institutes	Institutes	NNPS
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	18	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	19	Health	Health	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	11	20	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	1	1981	1981	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	2	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	3	V'ol	V'ol	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	4	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	5	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	6	NIH	NIH	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	7	No	no	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	8	81	81	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	9	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	10	2034	2034	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	11	;	;	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	12	V!ol	V!ol	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	13	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	14	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	15	NIH	NIH	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	16	No	no	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	17	81	81	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	18	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	19	0235	0235	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	12	20	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	13	1	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	13	2	Kannel	Kannel	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	13	3	W'B	W'B	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	13	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	13	5	Neaton	Neaton	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	13	6	JD	JD	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	13	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	13	8	Wentworth	Wentworth	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	13	9	D	D	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	13	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	13	11	et	et	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	13	12	al	al	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	13	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	1	Overall	overall	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	2	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	3	coronary	coronary	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	4	heart	heart	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	5	disease	disease	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	6	mortaltt	mortaltt	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	7	ratcs	ratcs	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	8	itn	itn	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	9	relation	relation	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	10	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	11	majlr	majlr	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	12	risk	risk	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	13	tfactors	tfactor	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	14	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	15	325	325	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	16	348	348	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	17	men	man	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	18	screened	screen	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	19	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	20	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	21	multiple	multiple	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	22	risk	risk	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	23	factor	factor	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	24	intervention	intervention	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	25	trial	trial	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	14	26	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	15	1	Am	Am	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	15	2	Heart	Heart	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	15	3	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	15	4	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	15	5	1986;112:825	1986;112:825	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	15	6	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	15	7	36	36	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	15	8	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	16	1	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	16	2	Sinnett	Sinnett	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	16	3	PF	PF	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	16	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	16	5	V'hyto	V'hyto	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	16	6	HM	HM	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	16	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	1	ELpidemiological	elpidemiological	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	2	studies	study	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	3	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	4	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	5	total	total	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	6	highland	highland	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	7	population	population	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	8	-	-	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	9	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	10	ukisenta	ukisenta	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	11	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	12	Ncw	Ncw	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	13	Guinca	Guinca	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	14	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	15	cardiovascular	cardiovascular	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	16	disease	disease	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	17	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	18	relevant	relevant	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	19	clinical	clinical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	20	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	21	electrocardiographic	electrocardiographic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	22	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	23	radiologic	radiologic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	24	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	25	biochemical	biochemical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	26	findings	finding	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	17	27	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	18	1	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	18	2	Chronic	Chronic	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	18	3	Dis	Dis	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	18	4	1973;26:265	1973;26:265	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	18	5	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	18	6	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	18	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	19	1	5	5	LS
work_dkfzaqe2ezbwvieo2gzsrnlssu	19	2	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	19	3	I	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	19	4	ruswell	ruswell	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	19	5	AS	AS	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	19	6	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	19	7	Kcnnellv	Kcnnellv	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	19	8	MB	MB	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	19	9	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	19	10	Hansen	Hansen	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	19	11	JDL	JDL	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	19	12	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	19	13	Lee	Lee	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	19	14	RB	RB	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	19	15	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	20	1	Blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	20	2	pressures	pressure	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	20	3	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	20	4	!	!	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	20	5	kung	kung	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	20	6	bushmen	bushman	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	20	7	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	20	8	northern	northern	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	20	9	Botswana	Botswana	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	20	10	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	21	1	Am	Am	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	21	2	Heart	heart	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	21	3	]	]	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	21	4	1972;84:5	1972;84:5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	21	5	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	21	6	12	12	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	21	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	22	1	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	22	2	Shaper	Shaper	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	22	3	AG	AG	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	22	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	22	5	W'right	W'right	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	22	6	DH	DH	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	22	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	22	8	Kyobe	Kyobe	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	22	9	J.	J.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	23	1	Blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	23	2	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	23	3	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	23	4	body	body	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	23	5	build	build	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	23	6	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	23	7	three	three	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	23	8	nomadic	nomadic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	23	9	tribes	tribe	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	23	10	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	23	11	northern	northern	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	23	12	Kenya	Kenya	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	23	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	24	1	East	East	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	24	2	Afr	Afr	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	24	3	MedJ	MedJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	24	4	1969;46:273	1969;46:273	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	24	5	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	24	6	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	24	7	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	24	8	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	1	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	2	Shaper	Shaper	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	3	AG	AG	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	5	Leonard	Leonard	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	6	PJ	PJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	8	Jones	Jones	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	9	KW	KW	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	11	Jones	Jones	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	12	M.	M.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	13	Environmental	Environmental	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	14	effects	effect	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	15	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	16	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	17	body	body	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	18	build	build	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	19	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	20	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	21	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	22	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	23	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	24	chemistry	chemistry	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	25	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	26	nomadic	nomadic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	27	warriors	warrior	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	28	serving	serve	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	29	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	30	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	31	armv	armv	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	32	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	33	Kenya	Kenya	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	25	34	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	26	1	East	East	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	26	2	AfrMedJ	AfrMedJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	26	3	1969;46:282	1969;46:282	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	26	4	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	26	5	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	26	6	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	1	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	2	Seser	Seser	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	3	P	P	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	5	Gordon	Gordon	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	6	D	D	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	8	Peart	Peart	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	9	WS	WS	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	11	Beighton	Beighton	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	12	P.	P.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	13	Blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	14	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	15	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	16	its	-PRON-	PRP$
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	17	correlates	correlate	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	18	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	19	urban	urban	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	20	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	21	tribal	tribal	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	22	Africa	Africa	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	27	23	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	28	1	Lancet	Lancet	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	28	2	1980;ii:60	1980;ii:60	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	28	3	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	28	4	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	28	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	1	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	2	Cruz	Cruz	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	3	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	4	Coke	Coke	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	5	R	R	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	6	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	7	Etcheverry	Etcheverry	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	8	R	R	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	9	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	10	Nagel	Nagel	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	11	R.	R.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	12	Influence	Influence	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	13	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	14	migration	migration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	15	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	16	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	17	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	18	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	19	Easter	Easter	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	20	Islanders	Islanders	NNPS
work_dkfzaqe2ezbwvieo2gzsrnlssu	29	21	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	30	1	Lancet	Lancet	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	30	2	1964;i:697	1964;i:697	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	30	3	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	30	4	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	30	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	1	1	1	LS
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	2	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	3	Sever	Sever	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	4	PS	PS	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	5	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	6	Poulter	Poulter	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	7	N.	N.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	8	An	an	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	9	hypothesis	hypothesis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	10	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	11	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	12	pathogenesis	pathogenesis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	13	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	14	essential	essential	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	15	hypertension	hypertension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	16	based	base	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	17	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	18	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	19	new	new	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	20	model	model	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	21	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	22	migration	migration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	23	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	24	induced	induce	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	25	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	26	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	27	elevation	elevation	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	31	28	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	32	1	In	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	32	2	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	32	3	Hofman	Hofman	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	32	4	A	A	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	32	5	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	32	6	Grobbee	Grobbee	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	32	7	DE	DE	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	32	8	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	32	9	Schalekamp	Schalekamp	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	32	10	MADH	MADH	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	32	11	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	32	12	eds	eds	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	32	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	33	1	Early	early	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	33	2	pathuogernesis	pathuogernesis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	33	3	of/'prnmarv	of/'prnmarv	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	33	4	hYpertension	hYpertension	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	33	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	34	1	Amsterdam	Amsterdam	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	34	2	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	34	3	Elsevier	Elsevier	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	34	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	34	5	1987	1987	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	34	6	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	35	1	11	11	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	35	2	Poulter	Poulter	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	35	3	NR	NR	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	35	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	35	5	Khaw	Khaw	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	35	6	KlT	KlT	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	35	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	35	8	Hopwood	Hopwood	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	35	9	BEC	BEC	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	35	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	35	11	ei	ei	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	35	12	al	al	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	35	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	36	1	Blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	36	2	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	36	3	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	36	4	its	-PRON-	PRP$
work_dkfzaqe2ezbwvieo2gzsrnlssu	36	5	correlates	correlate	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	36	6	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	36	7	an	an	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	36	8	African	african	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	36	9	tribe	tribe	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	36	10	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	36	11	urban	urban	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	36	12	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	36	13	rural	rural	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	36	14	environments	environment	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	36	15	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	37	1	J	J	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	37	2	EpidemiolCommunity	EpidemiolCommunity	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	37	3	hfealth	hfealth	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	37	4	1984;38:181	1984;38:181	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	37	5	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	37	6	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	37	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	38	1	12	12	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	38	2	Poulter	Poulter	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	38	3	NR	NR	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	38	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	38	5	Khaw	Khaw	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	38	6	KT	KT	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	38	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	38	8	Sever	Sever	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	38	9	PS	PS	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	38	10	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	1	Higher	high	JJR
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	2	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	3	pressuLres	pressulre	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	4	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	5	urbani	urbani	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	6	mnigranits	mnigranit	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	7	from	from	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	8	an	an	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	9	Af'rican	af'rican	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	10	low	low	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	11	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	12	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	13	po)pulationi	po)pulationi	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	14	are	be	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	15	not	not	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	16	duIe	duie	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	17	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	18	selective	selective	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	19	migration	migration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	39	20	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	40	1	Amj	Amj	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	40	2	Hvilperiens	Hvilperiens	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	40	3	1988;1:143	1988;1:143	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	40	4	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	40	5	5S.	5s.	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	41	1	13	13	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	41	2	I'oulter	i'oulter	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	41	3	NR	NR	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	41	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	41	5	Lury	Lury	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	41	6	Ji	Ji	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	41	7	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	41	8	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	41	9	rhompson	rhompson	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	41	10	A.	A.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	42	1	Blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	42	2	pressuires	pressuire	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	42	3	higher	higher	RBR
work_dkfzaqe2ezbwvieo2gzsrnlssu	42	4	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	42	5	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	42	6	home	home	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	42	7	than	than	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	42	8	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	42	9	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	42	10	clinic	clinic	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	42	11	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	42	12	rural	rural	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	42	13	Kenya	Kenya	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	42	14	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	43	1	]	]	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	43	2	1Epidemlol	1Epidemlol	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	43	3	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	43	4	Communiuv	Communiuv	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	43	5	Health	Health	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	43	6	1986;40:186	1986;40:186	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	43	7	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	43	8	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	43	9	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	44	1	14	14	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	44	2	Medical	Medical	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	44	3	Research	Research	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	44	4	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	44	5	Council	Council	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	44	6	Working	Working	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	44	7	Party	Party	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	44	8	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	45	1	MRC	MRC	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	45	2	trial	trial	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	45	3	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	45	4	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	45	5	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	45	6	mild	mild	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	45	7	hypertension	hypertension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	45	8	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	46	1	Br	br	UH
work_dkfzaqe2ezbwvieo2gzsrnlssu	46	2	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	46	3	Medj	Medj	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	46	4	1985;291:97	1985;291:97	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	46	5	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	46	6	104	104	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	46	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	47	1	15	15	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	47	2	Rose	Rose	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	47	3	G.	G.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	47	4	Strategy	Strategy	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	47	5	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	47	6	prevention	prevention	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	47	7	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	47	8	lessons	lesson	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	47	9	from	from	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	47	10	cardiovascular	cardiovascular	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	47	11	disease	disease	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	47	12	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	48	1	Br	br	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	48	2	Med7	med7	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	48	3	1981	1981	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	48	4	;	;	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	48	5	282:1847	282:1847	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	48	6	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	48	7	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	48	8	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	48	9	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	49	1	16	16	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	49	2	Meneely	meneely	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	49	3	GR	GR	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	49	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	49	5	Battarbee	Battarbee	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	49	6	HD	HD	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	49	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	50	1	High	high	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	50	2	sodium	sodium	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	50	3	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	50	4	low	low	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	50	5	potassium	potassium	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	50	6	environment	environment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	50	7	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	50	8	hypertension	hypertension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	50	9	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	51	1	Am	Am	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	51	2	]	]	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	51	3	Cardiol	Cardiol	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	51	4	1976;38:768	1976;38:768	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	51	5	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	51	6	84	84	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	51	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	52	1	17	17	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	52	2	Langford	Langford	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	52	3	HG	HG	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	52	4	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	53	1	Dietary	dietary	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	53	2	potassium	potassium	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	53	3	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	53	4	hypertension	hypertension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	53	5	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	53	6	epidemiologic	epidemiologic	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	53	7	data	datum	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	53	8	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	54	1	Ann	Ann	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	54	2	InternMed	InternMed	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	54	3	1983;98:770	1983;98:770	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	54	4	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	54	5	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	54	6	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	1	18	18	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	2	Khaw	Khaw	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	3	KT	KT	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	5	Rose	Rose	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	6	G.	G.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	7	IPopulation	IPopulation	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	8	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	9	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	10	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	11	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	12	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	13	associated	associate	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	14	f'actors	f'actors	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	15	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	16	St	St	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	17	Lucia	Lucia	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	18	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	19	West	West	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	20	Indies	Indies	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	55	21	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	56	1	Inr]Epidemiol	inr]epidemiol	PRP$
work_dkfzaqe2ezbwvieo2gzsrnlssu	56	2	1982;11:372	1982;11:372	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	56	3	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	56	4	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	56	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	57	1	19	19	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	57	2	Rikimaru	Rikimaru	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	57	3	T	T	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	57	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	57	5	Fujita	Fujita	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	57	6	Y	Y	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	57	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	57	8	Okuda	Okuda	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	57	9	r	r	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	57	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	57	11	et	et	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	57	12	al	al	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	57	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	1	Responses	response	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	2	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	3	sodium	sodium	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	4	balance	balance	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	5	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	6	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	7	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	8	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	9	other	other	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	10	variables	variable	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	11	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	12	sodium	sodium	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	13	loading	loading	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	14	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	15	Papua	Papua	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	16	New	New	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	17	Guinea	Guinea	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	18	highlanders	highlander	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	58	19	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	59	1	Am	Am	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	59	2	]	]	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	59	3	Clin	Clin	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	59	4	Nutr	Nutr	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	59	5	1988;47:502	1988;47:502	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	59	6	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	59	7	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	59	8	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	60	1	20	20	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	60	2	Scotch	scotch	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	60	3	NA	NA	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	60	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	60	5	Geiger	Geiger	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	60	6	JH	JH	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	60	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	61	1	Epidemiology	epidemiology	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	61	2	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	61	3	essential	essential	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	61	4	hypertension	hypertension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	61	5	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	61	6	psycholiogic	psycholiogic	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	61	7	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	61	8	socio	socio	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	61	9	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	61	10	cultural	cultural	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	61	11	factors	factor	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	61	12	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	61	13	etiology	etiology	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	61	14	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	61	15	]	]	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	62	1	Chronic	Chronic	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	62	2	D)is	D)is	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	62	3	1963;16:1183	1963;16:1183	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	62	4	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	62	5	213	213	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	62	6	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	1	21	21	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	2	Poulter	Poulter	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	3	NR	NR	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	5	Shipley	Shipley	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	6	MJ	MJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	8	Bulpitt	Bulpitt	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	9	CJ	CJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	11	Markowe	Markowe	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	12	HJ	HJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	13	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	14	Marmot	Marmot	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	15	MG	MG	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	16	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	17	Pulse	pulse	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	18	rate	rate	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	19	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	20	24	24	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	21	hour	hour	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	22	urinarv	urinarv	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	23	sodium	sodium	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	24	content	content	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	25	interact	interact	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	26	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	27	determine	determine	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	28	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	29	prcssure	prcssure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	30	levels	level	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	31	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	32	male	male	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	33	London	London	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	34	civil	civil	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	35	servants	servant	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	63	36	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	64	1	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	64	2	Hsvpertens	Hsvpertens	NNPS
work_dkfzaqe2ezbwvieo2gzsrnlssu	64	3	1988;6(suppl	1988;6(suppl	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	64	4	4):611	4):611	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	64	5	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	64	6	3S.	3s.	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	65	1	22	22	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	65	2	Koepke	Koepke	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	65	3	JP	JP	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	65	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	65	5	DiBona	DiBona	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	65	6	GF	GF	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	65	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	1	High	high	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	2	sodium	sodium	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	3	intake	intake	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	4	enhances	enhance	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	5	renal	renal	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	6	nerve	nerve	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	7	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	8	anti	anti	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	9	-	-	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	10	natriuretic	natriuretic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	11	responses	response	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	12	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	13	stress	stress	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	14	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	15	spontaneously	spontaneously	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	16	hypertensive	hypertensive	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	17	rats	rat	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	66	18	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	67	1	Hytpertension	hytpertension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	67	2	1985;7:357	1985;7:357	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	67	3	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	67	4	63	63	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	67	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	68	1	23	23	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	68	2	Light	Light	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	68	3	KC	KC	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	68	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	68	5	Koepke	Koepke	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	68	6	JP	JP	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	68	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	68	8	Obrist	Obrist	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	68	9	PA	PA	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	68	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	68	11	Willis	Willis	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	68	12	PW	PW	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	68	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	69	1	Psychological	psychological	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	69	2	stress	stress	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	69	3	induces	induce	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	69	4	sodium	sodium	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	69	5	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	69	6	fluid	fluid	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	69	7	retention	retention	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	69	8	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	69	9	men	man	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	69	10	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	69	11	high	high	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	69	12	risk	risk	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	69	13	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	69	14	hypertension	hypertension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	69	15	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	70	1	Science	Science	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	70	2	1983;220:429	1983;220:429	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	70	3	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	70	4	31	31	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	70	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	71	1	24	24	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	71	2	Intersalt	Intersalt	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	71	3	Cooperative	Cooperative	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	71	4	Research	Research	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	71	5	Group	Group	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	71	6	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	72	1	Intersalt	Intersalt	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	72	2	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	72	3	an	an	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	72	4	international	international	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	72	5	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	72	6	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	72	7	electrolyte	electrolyte	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	72	8	excretion	excretion	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	72	9	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	72	10	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	72	11	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	72	12	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	73	1	Results	result	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	73	2	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	73	3	24	24	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	73	4	hour	hour	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	73	5	urinary	urinary	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	73	6	sodium	sodium	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	73	7	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	73	8	potassium	potassium	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	73	9	excretion	excretion	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	73	10	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	74	1	BrMedj	BrMedj	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	74	2	1988;297:319	1988;297:319	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	74	3	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	74	4	28	28	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	74	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	75	1	25	25	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	75	2	Straessen	Straessen	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	75	3	J	J	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	75	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	75	5	Bulpitt	Bulpitt	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	75	6	CJ	CJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	75	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	75	8	Thijs	Thijs	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	75	9	L	L	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	75	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	75	11	et	et	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	75	12	al	al	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	75	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	76	1	Svmpathetic	svmpathetic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	76	2	tone	tone	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	76	3	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	76	4	relation	relation	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	76	5	between	between	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	76	6	sodium	sodium	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	76	7	intake	intake	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	76	8	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	76	9	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	76	10	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	76	11	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	76	12	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	76	13	general	general	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	76	14	population	population	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	76	15	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	77	1	Br	br	UH
work_dkfzaqe2ezbwvieo2gzsrnlssu	77	2	Med	Med	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	77	3	]	]	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	77	4	1989;299:1502	1989;299:1502	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	77	5	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	77	6	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	77	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	78	1	26	26	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	78	2	Folkow	Folkow	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	78	3	B	B	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	78	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	78	5	Grimby	Grimby	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	78	6	!	!	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	79	1	G	G	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	79	2	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	79	3	Thelesius	Thelesius	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	79	4	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	79	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	1	Adaptive	adaptive	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	2	structural	structural	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	3	changes	change	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	4	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	5	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	6	vascular	vascular	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	7	walls	wall	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	8	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	9	hypertension	hypertension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	10	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	11	their	-PRON-	PRP$
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	12	relation	relation	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	13	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	14	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	15	control	control	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	16	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	17	peripheral	peripheral	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	18	resistance	resistance	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	80	19	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	81	1	Acta	Acta	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	81	2	PhvsiolScand	PhvsiolScand	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	81	3	1958;44:255	1958;44:255	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	81	4	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	81	5	72	72	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	81	6	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	82	1	27	27	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	82	2	Lever	Lever	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	82	3	AF	AF	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	82	4	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	83	1	Slow	slow	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	83	2	pressor	pressor	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	83	3	mechanisms	mechanism	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	83	4	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	83	5	hypertension	hypertension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	83	6	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	83	7	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	83	8	role	role	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	83	9	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	83	10	hypertrophy	hypertrophy	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	83	11	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	83	12	resistance	resistance	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	83	13	vessels	vessel	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	83	14	?	?	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	84	1	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	84	2	Hvpertens	Hvpertens	NNPS
work_dkfzaqe2ezbwvieo2gzsrnlssu	84	3	1986;4:515	1986;4:515	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	84	4	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	84	5	24	24	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	84	6	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	85	1	28	28	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	85	2	Klatsky	Klatsky	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	85	3	AL	AL	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	85	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	85	5	Friedman	Friedman	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	85	6	GD	GD	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	85	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	85	8	Seigelaub	Seigelaub	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	85	9	AB	AB	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	85	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	85	11	Gerard	Gerard	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	85	12	MJ	MJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	85	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	86	1	Alcohol	alcohol	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	86	2	consumption	consumption	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	86	3	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	86	4	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	86	5	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	86	6	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	86	7	Kaiser	Kaiser	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	86	8	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	86	9	Permanente	Permanente	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	86	10	multiphasic	multiphasic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	86	11	health	health	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	86	12	examination	examination	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	86	13	data	datum	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	86	14	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	87	1	N	N	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	87	2	Engli	Engli	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	87	3	Med	Med	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	87	4	1977;296:1194	1977;296:1194	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	87	5	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	87	6	200	200	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	87	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	88	1	29	29	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	88	2	Carvalho	Carvalho	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	88	3	JJM	JJM	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	88	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	88	5	Baruzzi	Baruzzi	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	88	6	RG	RG	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	88	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	88	8	Howard	Howard	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	88	9	PF	PF	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	88	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	88	11	ei	ei	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	88	12	al	al	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	88	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	89	1	Blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	89	2	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	89	3	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	89	4	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	89	5	isolated	isolate	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	89	6	small	small	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	89	7	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	89	8	village	village	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	89	9	populations	population	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	89	10	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	89	11	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	89	12	Intersalt	Intersalt	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	89	13	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	89	14	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	90	1	Hvpertenston	Hvpertenston	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	90	2	1989;14:238-	1989;14:238-	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	90	3	46	46	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	90	4	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	1	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	2	Accepted	Accepted	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	3	15]anuarv	15]anuarv	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	4	1990	1990	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	5	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	6	Oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	7	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	8	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	9	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	10	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	11	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	12	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	13	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	14	Mary	Mary	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	15	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	16	Paula	Paula	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	17	Colgan	Colgan	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	18	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	19	John	John	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	20	A	A	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	21	Dormandy	Dormandy	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	22	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	23	Peter	Peter	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	24	W	W	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	25	Jones	Jones	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	26	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	27	Ivor	Ivor	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	28	G	G	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	29	Schraibman	Schraibman	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	30	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	31	D	D	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	32	Gregor	Gregor	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	33	Shanik	Shanik	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	34	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	35	Richard	Richard	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	36	A	A	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	37	L	L	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	38	Young	Young	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	39	Abstract	Abstract	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	40	Objective	Objective	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	41	-	-	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	42	To	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	43	determine	determine	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	44	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	45	effect	effect	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	46	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	47	oxpenti-	oxpenti-	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	48	fylline	fylline	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	49	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	50	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	51	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	52	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	53	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	54	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	55	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	56	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	57	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	91	58	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	92	1	Design	design	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	92	2	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	92	3	Double	double	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	92	4	blind	blind	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	92	5	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	92	6	randomised	randomised	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	92	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	92	8	prospective	prospective	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	92	9	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	92	10	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	92	11	controlled	control	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	92	12	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	92	13	parallel	parallel	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	92	14	group	group	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	92	15	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	92	16	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	93	1	Setting	set	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	93	2	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	93	3	Four	four	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	93	4	outpatient	outpatient	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	93	5	clinics	clinic	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	93	6	treating	treat	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	93	7	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	93	8	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	93	9	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	93	10	England	England	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	93	11	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	93	12	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	93	13	Republic	Republic	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	93	14	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	93	15	Ireland	Ireland	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	93	16	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	1	Patients-80	Patients-80	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	2	Consecutive	consecutive	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	3	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	4	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	5	clinical	clinical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	6	evidence	evidence	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	7	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	8	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	9	ulceration	ulceration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	10	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	11	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	12	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	13	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	14	whom	whom	WP
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	15	appreciable	appreciable	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	16	arterial	arterial	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	17	disease	disease	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	18	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	19	excluded	exclude	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	20	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	21	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	22	ratio	ratio	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	23	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	24	ankle	ankle	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	25	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	26	brachial	brachial	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	27	systolic	systolic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	28	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	29	being	be	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	30	>	>	XX
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	31	0	0	NFP
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	32	*	*	NFP
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	33	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	94	34	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	1	Interventions	intervention	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	2	-	-	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	3	All	all	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	4	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	5	received	receive	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	6	either	either	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	7	ox-	ox-	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	8	pentifylline	pentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	9	400	400	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	10	mg	mg	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	11	three	three	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	12	times	time	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	13	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	14	day	day	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	15	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	16	mouth	mouth	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	17	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	18	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	19	matching	match	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	20	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	21	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	22	six	six	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	23	months	month	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	24	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	25	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	26	until	until	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	27	their	-PRON-	PRP$
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	28	reference	reference	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	29	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	30	healed	heal	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	31	if	if	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	32	this	this	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	33	occurred	occur	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	34	sooner	sooner	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	35	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	36	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	37	addition	addition	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	38	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	39	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	40	locally	locally	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	41	standardised	standardised	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	42	method	method	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	43	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	44	com-	com-	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	45	pression	pression	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	46	bandaging	bandage	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	95	47	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	1	Main	main	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	2	outcome	outcome	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	3	measures	measure	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	4	-	-	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	5	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	6	primary	primary	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	7	end	end	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	8	point	point	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	9	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	10	complete	complete	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	11	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	12	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	13	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	14	reference	reference	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	15	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	16	within	within	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	17	six	six	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	18	months	month	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	96	19	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	2	secondary	secondary	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	3	end	end	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	4	point	point	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	5	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	6	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	7	change	change	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	8	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	9	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	10	area	area	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	11	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	12	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	13	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	14	over	over	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	15	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	16	six	six	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	17	month	month	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	18	observa-	observa-	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	19	tion	tion	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	20	period	period	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	97	21	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	1	Results	result	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	2	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	3	Complete	complete	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	4	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	5	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	6	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	7	reference	reference	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	8	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	9	occurred	occur	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	10	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	11	23	23	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	12	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	13	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	14	38	38	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	15	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	16	treated	treat	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	17	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	18	oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	19	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	20	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	21	12	12	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	22	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	23	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	24	42	42	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	25	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	26	treated	treat	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	27	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	28	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	29	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	98	30	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	1	Life	life	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	2	table	table	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	3	analysis	analysis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	4	showed	show	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	5	that	that	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	6	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	7	proportion	proportion	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	8	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	9	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	10	healed	heal	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	11	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	12	six	six	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	13	months	month	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	14	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	15	64	64	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	16	%	%	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	17	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	18	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	19	group	group	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	20	treated	treat	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	21	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	22	oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	23	compared	compare	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	24	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	25	34	34	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	26	%	%	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	27	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	28	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	29	group	group	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	30	treated	treat	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	31	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	32	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	33	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	34	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	35	log	log	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	36	rank	rank	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	37	test	test	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	38	X2=4	X2=4	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	39	-	-	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	40	78	78	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	41	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	42	p=003	p=003	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	43	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	44	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	45	which	which	WDT
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	46	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	47	significant	significant	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	48	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	49	odds	odd	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	50	ratio=	ratio=	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	51	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	52	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	53	81	81	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	54	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	55	95	95	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	56	%	%	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	57	confidence	confidence	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	58	interval	interval	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	59	1X20	1x20	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	60	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	61	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	62	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	63	71	71	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	64	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	99	65	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	1	Conclusion	Conclusion	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	2	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	3	Oxpentifylline	Oxpentifylline	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	4	used	use	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	5	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	6	conjunction	conjunction	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	7	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	8	compression	compression	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	9	bandaging	bandaging	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	10	improves	improve	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	11	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	12	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	13	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	14	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	15	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	16	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	17	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	18	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	100	19	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	101	1	Introduction	introduction	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	101	2	Venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	101	3	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	101	4	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	101	5	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	101	6	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	101	7	are	be	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	101	8	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	101	9	common	common	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	101	10	cause	cause	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	101	11	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	101	12	illness	illness	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	101	13	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	101	14	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	101	15	community	community	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	101	16	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	2	condition	condition	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	3	has	have	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	4	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	5	preva-	preva-	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	6	lence	lence	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	7	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	8	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	9	%	%	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	11	which	which	WDT
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	12	is	be	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	13	similar	similar	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	14	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	15	that	that	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	16	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	17	diabetes	diabete	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	18	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	19	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	20	it	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	21	recurs	recur	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	22	chronically	chronically	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	23	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	102	24	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	1	Ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	2	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	3	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	4	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	5	are	be	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	6	expensive	expensive	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	7	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	8	treat	treat	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	9	as	as	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	10	they	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	11	require	require	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	12	regular	regular	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	13	dressing	dressing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	14	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	15	often	often	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	16	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	17	district	district	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	18	nurses	nurse	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	103	19	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	2	cost	cost	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	3	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	4	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	5	NHS	NHS	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	6	has	have	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	7	been	be	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	8	estimated	estimate	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	9	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	10	be	be	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	11	£	£	$
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	12	1200	1200	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	13	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	14	each	each	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	15	unhealed	unhealed	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	16	ulcer	ulcer	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	17	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	18	year.7	year.7	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	19	At	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	20	present	present	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	21	there	there	EX
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	22	is	be	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	23	no	no	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	24	proved	proved	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	25	pharmacological	pharmacological	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	26	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	27	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	28	but	but	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	29	this	this	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	30	is	be	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	31	not	not	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	32	surprising	surprising	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	33	as	as	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	34	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	35	pathophysiology	pathophysiology	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	36	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	37	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	38	ulceration	ulceration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	39	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	40	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	41	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	42	is	be	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	43	poorly	poorly	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	44	understood	understand	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	104	45	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	1	Two	two	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	2	hypotheses	hypothesis	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	3	have	have	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	4	been	be	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	5	advanced	advance	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	6	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	7	explain	explain	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	8	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	9	occurrence	occurrence	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	10	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	11	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	12	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	13	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	14	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	15	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	16	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	17	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	18	context	context	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	19	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	20	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	21	postphlebitic	postphlebitic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	22	syndrome	syndrome	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	105	23	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	1	"	"	``
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	2	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	3	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	4	first	first	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	5	hypothesis	hypothesis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	6	relates	relate	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	7	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	8	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	9	formation	formation	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	10	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	11	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	12	pericapillary	pericapillary	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	13	cuff	cuff	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	14	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	15	fibrin	fibrin	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	16	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	17	which	which	WDT
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	18	acts	act	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	19	as	as	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	20	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	21	barrier	barrier	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	22	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	23	diffusion	diffusion	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	24	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	25	leads	lead	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	26	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	27	local	local	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	28	ischaemia	ischaemia	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	29	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	30	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	31	tissues	tissue	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	32	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	106	33	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	1	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	2	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	3	second	second	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	4	hypothesis	hypothesis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	5	concerns	concern	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	6	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	7	phenomenon	phenomenon	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	8	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	9	white	white	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	10	cell	cell	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	11	trapping	trapping	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	12	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	13	which	which	WDT
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	14	aggravates	aggravate	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	15	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	16	trophic	trophic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	17	skin	skin	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	18	changes	change	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	19	that	that	WDT
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	20	are	be	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	21	typically	typically	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	22	seen	see	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	23	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	24	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	25	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	26	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	27	hypertension	hypertension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	28	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	29	"	"	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	107	30	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	1	Oxpentifylline	Oxpentifylline	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	2	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	3	Trentai	Trentai	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	5	Hoechst	Hoechst	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	6	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	7	has	have	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	8	been	be	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	9	found	find	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	10	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	11	have	have	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	12	fibrinolytic	fibrinolytic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	13	effects9	effects9	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	14	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	15	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	16	influence	influence	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	17	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	18	behaviour	behaviour	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	19	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	20	white	white	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	21	cells	cell	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	22	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	23	"	"	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	108	24	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	1	It	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	2	therefore	therefore	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	3	seemed	seem	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	4	reasonable	reasonable	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	5	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	6	study	study	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	7	Vascular	Vascular	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	8	Laboratories	Laboratories	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	9	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	10	St	St	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	11	James	James	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	12	's	's	POS
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	13	Hospital	Hospital	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	14	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	15	PO	PO	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	16	Box	Box	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	17	580	580	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	18	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	19	Dublin	Dublin	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	20	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	21	Mary	Mary	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	22	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	23	Paula	Paula	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	24	Colgan	Colgan	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	25	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	26	MD	MD	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	27	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	28	director	director	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	29	St	St	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	30	George	George	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	31	's	's	POS
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	32	Hospital	Hospital	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	33	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	34	London	London	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	35	John	John	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	36	A	A	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	37	Dormandy	Dormandy	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	38	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	39	FRCS	FRCS	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	40	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	41	consultant	consultant	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	42	surgeon	surgeon	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	43	Department	Department	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	44	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	45	Mathematics	Mathematics	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	46	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	47	University	University	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	48	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	49	Keele	Keele	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	50	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	51	Staffordshire	Staffordshire	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	52	Peter	Peter	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	53	W	W	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	54	Jones	Jones	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	55	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	56	PHD	PHD	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	57	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	58	senior	senior	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	59	lecturer	lecturer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	60	Birch	Birch	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	61	Hill	Hill	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	62	Hospital	Hospital	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	63	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	64	Rochdale	Rochdale	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	65	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	66	Lancashire	Lancashire	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	67	Ivor	Ivor	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	68	G	G	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	69	Schraibman	Schraibman	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	70	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	71	FRCS	FRCS	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	72	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	73	consultant	consultant	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	74	surgeon	surgeon	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	75	Trinity	Trinity	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	76	College	College	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	77	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	78	Dublin	Dublin	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	79	D	D	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	80	Gregor	Gregor	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	81	Shanik	Shanik	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	82	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	83	FRCS	FRCS	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	84	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	85	professor	professor	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	86	ofvascular	ofvascular	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	87	surgery	surgery	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	88	West	West	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	89	Middlesex	Middlesex	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	90	University	University	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	91	Hospital	Hospital	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	92	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	93	Isleworth	Isleworth	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	94	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	95	Middlesex	Middlesex	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	96	Richard	Richard	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	97	A	A	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	98	L	L	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	99	Young	Young	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	100	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	101	FRCS	FRCS	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	102	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	103	consultant	consultant	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	104	surgeon	surgeon	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	105	Correspondence	Correspondence	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	106	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	107	requests	request	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	108	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	109	reprints	reprint	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	110	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	111	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	112	Dr	Dr	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	113	Colgan	Colgan	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	109	114	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	1	BrAWedj	BrAWedj	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	2	1990;300:972	1990;300:972	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	3	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	4	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	5	972	972	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	6	BMJ	BMJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	7	VOLUME	volume	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	8	300	300	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	9	14	14	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	10	APRIL	APRIL	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	11	1990	1990	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	12	o	o	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	13	n	n	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	14	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	15	A	a	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	16	p	p	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	17	ril	ril	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	18	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	19	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	20	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	21	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	22	b	b	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	23	y	y	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	24	g	g	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	25	u	u	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	26	e	e	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	27	st	st	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	28	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	29	P	P	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	30	ro	ro	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	31	te	te	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	32	cte	cte	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	33	d	d	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	34	b	b	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	35	y	y	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	36	co	co	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	37	p	p	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	38	yrig	yrig	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	39	h	h	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	40	t.	t.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	41	h	h	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	42	ttp	ttp	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	43	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	44	//w	//w	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	45	w	w	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	46	w	w	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	47	.b	.b	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	48	m	m	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	49	j.co	j.co	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	50	m	m	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	51	/	/	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	52	B	B	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	53	M	M	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	54	J	J	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	55	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	56	first	first	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	57	p	p	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	58	u	u	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	59	b	b	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	60	lish	lish	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	61	e	e	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	62	d	d	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	63	a	a	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	64	s	s	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	65	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	66	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	67	.1	.1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	68	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	69	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	70	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	71	/b	/b	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	72	m	m	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	73	j.3	j.3	$
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	74	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	75	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	76	.6	.6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	77	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	78	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	79	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	80	.9	.9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	81	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	82	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	83	o	o	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	84	n	n	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	85	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	86	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	87	A	A	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	88	p	p	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	89	ril	ril	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	90	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	91	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	92	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	93	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	110	94	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	1	D	D	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	2	o	o	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	3	w	w	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	4	n	n	XX
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	5	lo	lo	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	6	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	7	d	d	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	8	e	e	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	9	d	d	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	10	fro	fro	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	11	m	m	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	12	http://www.bmj.com/	http://www.bmj.com/	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	13	this	this	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	14	drug	drug	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	15	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	16	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	17	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	18	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	19	ulceration	ulceration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	20	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	21	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	22	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	111	23	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	1	Patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	2	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	3	methods	method	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	4	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	5	trial	trial	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	6	design	design	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	7	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	8	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	9	prospective	prospective	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	11	randomised	randomised	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	12	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	13	double	double	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	14	blind	blind	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	15	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	16	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	17	controlled	control	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	18	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	19	parallel	parallel	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	20	group	group	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	21	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	22	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	23	80	80	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	24	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	25	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	26	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	27	conducted	conduct	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	28	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	29	four	four	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	30	centres	centre	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	31	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	32	England	England	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	33	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	34	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	35	Republic	Republic	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	36	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	37	Ireland	Ireland	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	112	38	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	1	Consecutive	consecutive	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	2	eligible	eligible	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	3	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	4	attending	attend	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	5	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	6	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	7	ulcer	ulcer	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	8	clinic	clinic	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	9	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	10	each	each	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	11	centre	centre	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	12	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	13	randomised	randomise	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	14	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	15	receive	receive	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	16	either	either	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	17	oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	18	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	19	400	400	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	20	mg	mg	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	21	three	three	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	22	times	time	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	23	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	24	day	day	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	25	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	26	mouth	mouth	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	27	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	28	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	29	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	30	matching	match	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	31	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	113	32	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	114	1	Randomisation	randomisation	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	114	2	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	114	3	performed	perform	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	114	4	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	114	5	balanced	balanced	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	114	6	blocks	block	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	114	7	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	114	8	eight	eight	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	114	9	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	114	10	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	114	11	separate	separate	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	114	12	list	list	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	114	13	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	114	14	each	each	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	114	15	centre	centre	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	114	16	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	115	1	Treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	115	2	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	115	3	continued	continue	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	115	4	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	115	5	six	six	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	115	6	months	month	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	115	7	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	115	8	until	until	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	115	9	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	115	10	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	115	11	healed	heal	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	115	12	if	if	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	115	13	this	this	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	115	14	occurred	occur	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	115	15	sooner	soon	RBR
work_dkfzaqe2ezbwvieo2gzsrnlssu	115	16	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	1	Patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	2	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	3	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	4	that	that	WDT
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	5	had	have	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	6	shown	show	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	7	no	no	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	8	signs	sign	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	9	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	10	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	11	after	after	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	12	at	at	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	13	least	least	RBS
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	14	two	two	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	15	months	month	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	16	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	17	routine	routine	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	18	outpatient	outpatient	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	19	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	20	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	21	considered	consider	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	22	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	23	be	be	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	24	eligible	eligible	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	25	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	26	entry	entry	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	27	into	into	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	28	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	29	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	30	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	31	provided	provide	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	32	that	that	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	33	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	34	ulceration	ulceration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	35	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	36	clinically	clinically	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	37	thought	think	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	38	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	39	be	be	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	40	ofvenous	ofvenous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	41	origin	origin	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	42	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	43	that	that	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	44	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	45	ratio	ratio	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	46	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	47	ankle	ankle	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	48	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	49	brachial	brachial	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	50	systolic	systolic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	51	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	52	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	53	>	>	XX
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	54	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	55	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	56	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	57	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	58	that	that	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	59	there	there	EX
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	60	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	61	no	no	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	62	contraindication	contraindication	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	63	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	64	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	65	prescription	prescription	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	66	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	67	oxpenti-	oxpenti-	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	68	fylline	fylline	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	69	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	116	70	"	"	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	2	largest	large	JJS
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	3	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	4	present	present	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	5	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	6	selected	select	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	7	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	8	be	be	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	9	moni-	moni-	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	10	tored	tore	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	11	as	as	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	12	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	13	reference	reference	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	14	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	15	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	16	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	17	duration	duration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	18	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	19	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	20	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	21	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	22	provided	provide	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	23	that	that	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	24	its	-PRON-	PRP$
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	25	diameter	diameter	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	26	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	27	between	between	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	28	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	29	cm	cm	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	30	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	31	15	15	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	32	cm	cm	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	117	33	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	1	At	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	2	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	3	initial	initial	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	4	visit	visit	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	5	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	6	reference	reference	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	7	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	8	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	9	traced	trace	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	10	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	11	an	an	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	12	indelible	indelible	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	13	pen	pen	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	14	on	on	RP
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	15	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	16	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	17	transparent	transparent	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	18	acetate	acetate	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	19	sheet	sheet	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	20	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	118	21	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	119	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	119	2	number	number	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	119	3	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	119	4	additional	additional	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	119	5	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	119	6	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	119	7	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	119	8	also	also	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	119	9	documented	document	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	119	10	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	1	Patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	2	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	3	seen	see	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	4	every	every	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	5	two	two	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	6	weeks	week	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	7	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	8	six	six	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	9	months	month	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	10	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	11	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	12	reference	reference	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	13	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	14	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	15	traced	trace	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	16	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	17	alternate	alternate	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	18	visits	visit	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	120	19	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	121	1	An	an	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	121	2	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	121	3	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	121	4	considered	consider	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	121	5	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	121	6	be	be	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	121	7	healed	heal	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	121	8	only	only	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	121	9	when	when	WRB
work_dkfzaqe2ezbwvieo2gzsrnlssu	121	10	complete	complete	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	121	11	re	re	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	121	12	-	-	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	121	13	epithelialisation	epithelialisation	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	121	14	had	have	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	121	15	occurred	occur	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	121	16	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	122	1	Details	detail	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	122	2	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	122	3	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	122	4	dressings	dressing	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	122	5	used	use	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	122	6	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	122	7	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	122	8	four	four	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	122	9	centres	centre	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	122	10	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	122	11	recorded	record	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	122	12	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	1	Each	each	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	2	centre	centre	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	3	used	use	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	4	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	5	two	two	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	6	layer	layer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	7	method	method	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	8	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	9	bandaging	bandage	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	10	that	that	WDT
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	11	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	12	capable	capable	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	13	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	14	producing	produce	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	15	adequate	adequate	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	16	graduated	graduate	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	17	compression	compression	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	18	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	123	19	"	"	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	124	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	124	2	bandaging	bandaging	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	124	3	method	method	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	124	4	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	124	5	standardised	standardise	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	124	6	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	124	7	each	each	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	124	8	centre	centre	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	124	9	within	within	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	124	10	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	124	11	limits	limit	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	124	12	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	124	13	clinical	clinical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	124	14	practice	practice	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	124	15	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	1	All	all	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	2	centres	centre	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	3	liaised	liaise	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	4	closely	closely	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	5	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	6	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	7	local	local	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	8	community	community	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	9	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	10	district	district	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	11	nursing	nursing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	12	services	service	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	13	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	14	ensure	ensure	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	15	continuity	continuity	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	16	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	17	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	18	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	19	'	'	POS
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	20	dressings	dressing	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	21	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	22	home	home	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	23	between	between	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	24	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	25	visits	visit	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	125	26	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	126	1	A	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	126	2	computerised	computerised	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	126	3	system	system	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	126	4	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	126	5	developed	develop	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	126	6	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	126	7	measure	measure	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	126	8	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	126	9	area	area	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	126	10	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	126	11	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	126	12	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	126	13	from	from	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	126	14	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	126	15	tracing	tracing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	126	16	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	127	1	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	127	2	AUTOCAD	AUTOCAD	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	127	3	software	software	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	127	4	adapted	adapt	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	127	5	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	127	6	Datech	Datech	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	127	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	127	8	Orpington	Orpington	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	127	9	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	127	10	Kent	Kent	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	127	11	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	127	12	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	1	All	all	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	2	measurements	measurement	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	3	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	4	nmade	nmade	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	5	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	6	one	one	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	7	trained	train	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	8	observer	observer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	9	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	10	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	11	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	12	average	average	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	13	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	14	two	two	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	15	readings	reading	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	16	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	17	used	use	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	18	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	19	analysis	analysis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	128	20	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	129	1	Descriptive	descriptive	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	129	2	statistics	statistic	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	129	3	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	129	4	used	use	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	129	5	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	129	6	characterise	characterise	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	129	7	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	129	8	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	129	9	groups	group	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	129	10	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	129	11	baseline	baseline	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	129	12	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	1	'	'	``
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	2	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	3	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	4	statistical	statistical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	5	methods	method	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	6	included	include	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	7	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	8	X	x	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	9	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	10	test	test	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	11	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	12	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	13	log	log	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	14	rank	rank	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	15	test	test	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	16	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	17	which	which	WDT
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	18	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	19	used	use	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	20	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	21	compare	compare	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	22	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	23	two	two	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	24	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	25	groups	group	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	26	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	27	overall	overall	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	28	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	29	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	30	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	130	31	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	131	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	131	2	odds	odd	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	131	3	ratio	ratio	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	131	4	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	131	5	calculated	calculate	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	131	6	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	131	7	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	131	8	rate	rate	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	131	9	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	131	10	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	131	11	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	131	12	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	2	trial	trial	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	3	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	4	conducted	conduct	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	5	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	6	accordance	accordance	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	7	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	8	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	9	Declaration	Declaration	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	10	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	11	Helsinki	Helsinki	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	12	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	13	Venice	Venice	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	14	amendment	amendment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	15	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	16	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	17	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	18	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	19	protocol	protocol	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	20	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	21	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	22	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	23	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	24	approved	approve	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	25	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	26	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	27	ethics	ethics	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	28	committee	committee	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	29	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	30	each	each	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	31	centre	centre	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	132	32	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	133	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	133	2	informed	informed	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	133	3	consent	consent	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	133	4	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	133	5	each	each	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	133	6	patient	patient	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	133	7	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	133	8	obtained	obtain	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	133	9	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	133	10	writing	writing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	133	11	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	134	1	Results	Results	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	134	2	Eighty	eighty	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	134	3	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	134	4	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	134	5	randomly	randomly	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	134	6	allocated	allocate	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	134	7	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	134	8	receive	receive	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	134	9	either	either	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	134	10	oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	134	11	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	134	12	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	134	13	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	134	14	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	135	1	Table	table	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	135	2	I	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	135	3	shows	show	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	135	4	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	135	5	characteristics	characteristic	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	135	6	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	135	7	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	135	8	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	135	9	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	135	10	each	each	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	135	11	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	135	12	group	group	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	135	13	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	135	14	baseline	baseline	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	135	15	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	1	There	there	EX
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	2	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	3	no	no	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	4	differences	difference	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	5	between	between	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	6	treat-	treat-	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	7	ment	ment	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	8	groups	group	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	9	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	10	between	between	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	11	centres	centre	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	12	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	13	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	14	between	between	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	15	our	-PRON-	PRP$
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	16	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	17	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	18	those	those	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	19	surveyed	survey	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	20	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	21	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	22	recent	recent	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	23	epidemiological	epidemiological	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	24	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	25	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	26	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	27	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	28	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	29	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	30	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	136	31	"	"	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	2	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	3	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	4	quite	quite	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	5	healthy	healthy	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	6	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	7	their	-PRON-	PRP$
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	8	age	age	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	9	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	10	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	11	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	12	good	good	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	13	nutritional	nutritional	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	14	state	state	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	15	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	16	as	as	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	17	indicated	indicate	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	18	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	19	body	body	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	20	mass	mass	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	21	index	index	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	22	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	23	plasma	plasma	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	24	albumin	albumin	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	25	concentration	concentration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	137	26	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	1	One	one	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	2	patient	patient	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	3	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	4	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	5	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	6	group	group	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	7	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	8	withdrawn	withdraw	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	9	from	from	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	10	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	11	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	12	when	when	WRB
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	13	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	14	derma-	derma-	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	15	tologist	tologist	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	16	diagnosed	diagnose	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	17	pemphigoid	pemphigoid	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	18	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	19	an	an	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	20	atypical	atypical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	21	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	138	22	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	1	Complete	complete	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	2	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	3	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	4	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	5	reference	reference	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	6	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	7	occurred	occur	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	8	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	9	23	23	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	10	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	11	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	12	38	38	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	13	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	14	randomised	randomise	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	15	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	16	receive	receive	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	17	oxpenti-	oxpenti-	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	18	fylline	fylline	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	19	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	20	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	21	12	12	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	22	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	23	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	24	42	42	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	25	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	26	randomised	randomise	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	27	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	28	receive	receive	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	29	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	30	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	139	31	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	2	results	result	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	3	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	4	analysed	analyse	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	5	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	6	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	7	life	life	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	8	table	table	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	9	method	method	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	11	which	which	WDT
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	12	gives	give	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	13	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	14	proportion	proportion	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	15	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	16	reference	reference	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	17	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	18	healed	heal	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	19	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	20	each	each	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	21	visit	visit	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	22	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	23	takes	take	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	24	account	account	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	25	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	26	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	27	drop	drop	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	28	out	out	RP
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	29	rate	rate	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	140	30	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	141	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	141	2	results	result	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	141	3	are	be	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	141	4	shown	show	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	141	5	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	141	6	figure	figure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	141	7	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	141	8	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	1	By	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	2	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	3	end	end	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	4	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	5	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	6	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	7	64	64	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	8	%	%	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	9	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	10	reference	reference	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	11	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	12	had	have	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	13	healed	heal	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	14	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	15	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	16	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	17	treated	treat	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	18	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	19	oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	20	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	21	compared	compare	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	22	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	23	34	34	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	24	%	%	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	25	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	26	those	those	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	27	treated	treat	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	28	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	29	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	30	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	31	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	32	log	log	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	33	rank	rank	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	34	test	test	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	35	x2,=	x2,=	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	36	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	37	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	38	78	78	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	39	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	40	p=0	p=0	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	41	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	42	03	03	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	43	;	;	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	44	odds	odd	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	45	ratio=1	ratio=1	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	46	81	81	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	47	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	48	95	95	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	49	%	%	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	50	confidence	confidence	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	51	interval	interval	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	52	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	53	20	20	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	54	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	55	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	56	71	71	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	57	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	142	58	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	143	1	This	this	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	143	2	result	result	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	143	3	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	143	4	significant	significant	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	143	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	144	1	TABLE	TABLE	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	144	2	I	i	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	144	3	-Characteristics	-characteristic	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	144	4	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	144	5	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	144	6	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	144	7	entry	entry	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	144	8	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	144	9	studv	studv	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	144	10	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	1	V'alues	v'alue	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	2	are	be	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	3	means	mean	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	4	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	5	SD	sd	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	6	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	7	unless	unless	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	8	stated	state	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	9	otherwise	otherwise	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	10	Treatment	Treatment	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	11	group	group	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	12	Oxpentifylline	Oxpentifylline	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	13	Placebo	Placebo	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	14	Characteristic	Characteristic	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	15	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	16	n=	n=	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	17	38	38	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	18	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	19	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	20	n	n	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	21	=	=	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	22	42	42	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	23	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	24	Age	age	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	25	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	26	years	year	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	27	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	28	71	71	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	29	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	30	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	31	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	32	10	10	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	33	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	34	70	70	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	35	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	36	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	37	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	38	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	39	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	40	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	41	Sex	sex	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	42	ratio	ratio	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	43	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	44	M	m	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	45	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	46	F	f	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	47	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	48	9:29	9:29	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	49	14:28	14:28	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	50	Height	height	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	51	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	52	cm	cm	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	53	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	54	166	166	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	55	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	56	11	11	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	57	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	58	166	166	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	59	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	60	11	11	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	61	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	62	Weight	Weight	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	63	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	64	kg	kg	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	65	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	66	74	74	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	67	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	68	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	69	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	70	16	16	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	71	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	72	80	80	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	73	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	74	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	75	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	76	21	21	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	77	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	78	Bodv	Bodv	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	79	mass	mass	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	80	index	index	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	81	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	82	kg	kg	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	83	/	/	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	84	rm	rm	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	85	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	86	26	26	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	87	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	88	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	89	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	90	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	91	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	92	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	93	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	94	29	29	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	95	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	96	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	97	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	98	8)	8)	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	99	No	no	UH
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	100	who	who	WP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	101	smoked	smoke	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	102	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	103	never	never	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	104	smoked	smoke	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	105	22:16	22:16	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	106	26:16	26:16	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	107	Onset	Onset	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	108	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	109	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	110	disease	disease	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	111	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	112	years	year	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	113	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	114	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	115	median	median	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	116	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	117	IQR	IQR	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	118	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	119	17	17	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	120	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	121	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	122	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	123	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	124	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	125	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	126	31	31	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	127	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	128	18	18	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	129	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	130	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	131	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	132	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	133	26	26	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	134	Onset	onset	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	135	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	136	present	present	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	137	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	138	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	139	months	month	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	140	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	141	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	142	median	median	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	143	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	144	IQR	IQR	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	145	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	146	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	147	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	148	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	149	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	150	13	13	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	151	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	152	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	153	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	154	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	155	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	156	13	13	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	157	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	158	No	no	UH
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	159	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	160	history	history	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	161	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	162	varicose	varicose	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	163	veins	vein	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	164	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	165	phlebitis	phlebitis	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	166	30	30	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	167	30	30	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	168	Ankleindex	Ankleindex	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	169	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	170	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	171	05(0	05(0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	172	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	173	13	13	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	174	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	175	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	176	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	177	06(0	06(0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	178	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	179	14	14	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	180	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	181	Albumin	Albumin	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	182	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	183	g	g	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	184	/	/	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	185	l	l	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	186	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	187	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	188	median	median	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	189	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	190	IQR	IQR	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	191	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	192	40	40	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	193	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	194	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	195	38	38	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	196	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	197	43	43	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	198	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	199	40	40	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	200	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	201	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	202	38	38	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	203	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	204	43	43	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	205	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	206	Ulcer	Ulcer	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	207	area	area	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	208	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	209	cm-	cm-	XX
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	210	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	211	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	212	median	median	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	213	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	214	IQR	IQR	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	215	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	216	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	217	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	218	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	219	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	220	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	221	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	222	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	223	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	224	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	225	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	226	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	227	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	228	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	229	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	230	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	231	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	232	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	233	11	11	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	234	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	235	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	236	No	no	UH
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	237	without	without	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	238	other	other	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	239	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	240	20	20	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	241	18	18	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	242	No	no	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	243	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	244	other	other	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	245	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	246	18	18	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	247	24	24	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	248	IQR=	iqr=	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	249	Interquartile	Interquartile	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	250	range	range	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	145	251	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	146	1	1	1	LS
work_dkfzaqe2ezbwvieo2gzsrnlssu	146	2	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	146	3	a	a	LS
work_dkfzaqe2ezbwvieo2gzsrnlssu	146	4	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	146	5	a	a	LS
work_dkfzaqe2ezbwvieo2gzsrnlssu	146	6	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	146	7	a	a	LS
work_dkfzaqe2ezbwvieo2gzsrnlssu	146	8	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	146	9	0o	0o	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	146	10	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	146	11	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	1	00	00	NFP
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	2	00	00	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	3	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	4	o	o	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	5	Placebo	Placebo	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	6	*	*	NFP
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	7	Oxpentifylline	Oxpentifylline	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	8	Log	Log	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	9	rank	rank	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	10	test=4	test=4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	11	78	78	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	12	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	13	p=003	p=003	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	14	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	15	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	16	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	17	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	18	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	19	10	10	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	20	12	12	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	21	14	14	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	22	16	16	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	23	18	18	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	24	20	20	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	25	22	22	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	26	24	24	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	27	Time	time	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	28	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	29	weeks	week	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	30	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	31	FIG	FIG	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	32	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	33	-Life	-life	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	34	table	table	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	35	analysis	analysis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	36	ofproportion	ofproportion	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	37	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	38	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	39	healed	heal	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	40	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	41	each	each	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	42	visit	visit	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	43	Many	many	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	44	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	45	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	46	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	47	had	have	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	48	additional	additional	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	49	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	50	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	51	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	52	start	start	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	53	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	54	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	55	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	56	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	57	table	table	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	58	I	I	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	59	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	147	60	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	1	These	these	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	2	additional	additional	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	3	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	4	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	5	monitored	monitor	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	6	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	7	see	see	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	8	whether	whether	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	9	they	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	10	had	have	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	11	healed	heal	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	12	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	13	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	14	time	time	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	15	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	16	reference	reference	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	17	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	18	had	have	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	19	healed	heal	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	148	20	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	1	In	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	2	only	only	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	3	two	two	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	4	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	5	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	6	one	one	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	7	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	8	each	each	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	9	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	10	group	group	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	11	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	12	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	13	an	an	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	14	additional	additional	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	15	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	16	still	still	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	17	present	present	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	18	after	after	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	19	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	20	reference	reference	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	21	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	22	had	have	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	23	healed	heal	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	149	24	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	1	In	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	2	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	3	patient	patient	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	4	who	who	WP
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	5	received	receive	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	6	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	7	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	8	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	9	persistent	persistent	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	10	addi-	addi-	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	11	tional	tional	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	12	ulcer	ulcer	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	13	developed	develop	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	14	anew	anew	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	15	during	during	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	16	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	17	course	course	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	18	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	19	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	20	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	150	21	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	2	area	area	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	3	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	4	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	5	reference	reference	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	6	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	7	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	8	calculated	calculate	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	9	from	from	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	10	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	11	tracings	tracing	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	12	made	make	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	13	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	14	alternate	alternate	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	15	follow	follow	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	16	up	up	RP
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	17	visits	visit	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	151	18	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	2	median	median	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	3	area	area	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	4	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	5	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	6	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	7	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	8	each	each	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	9	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	10	group	group	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	11	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	12	each	each	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	13	follow	follow	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	14	up	up	RP
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	15	visit	visit	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	16	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	17	studied	study	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	18	so	so	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	19	that	that	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	20	information	information	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	21	could	could	MD
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	22	be	be	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	23	gained	gain	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	24	about	about	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	25	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	26	progress	progress	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	27	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	28	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	29	reference	reference	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	30	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	31	apart	apart	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	32	from	from	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	33	its	-PRON-	PRP$
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	34	complete	complete	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	35	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	152	36	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	1	These	these	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	2	results	result	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	3	are	be	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	4	presented	present	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	5	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	6	figure	figure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	7	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	8	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	9	which	which	WDT
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	10	shows	show	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	11	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	12	consistent	consistent	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	13	improvement	improvement	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	14	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	15	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	16	area	area	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	17	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	18	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	19	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	20	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	21	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	22	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	23	receiving	receive	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	24	oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	25	compared	compare	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	26	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	27	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	28	variable	variable	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	29	outcome	outcome	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	30	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	31	those	those	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	32	receiving	receive	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	33	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	34	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	153	35	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	1	A	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	2	reduction	reduction	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	3	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	4	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	5	area	area	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	6	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	7	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	8	reference	reference	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	9	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	10	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	11	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	12	final	final	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	13	visit	visit	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	14	relative	relative	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	15	BMJ	BMJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	16	VOLUME	volume	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	17	300	300	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	18	14	14	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	19	APRIL	APRIL	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	20	1990	1990	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	21	973	973	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	22	o	o	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	23	n	n	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	24	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	25	A	a	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	26	p	p	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	27	ril	ril	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	28	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	29	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	30	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	31	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	32	b	b	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	33	y	y	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	34	g	g	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	35	u	u	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	36	e	e	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	37	st	st	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	38	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	39	P	P	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	40	ro	ro	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	41	te	te	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	42	cte	cte	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	43	d	d	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	44	b	b	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	45	y	y	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	46	co	co	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	47	p	p	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	48	yrig	yrig	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	49	h	h	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	50	t.	t.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	51	h	h	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	52	ttp	ttp	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	53	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	54	//w	//w	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	55	w	w	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	56	w	w	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	57	.b	.b	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	58	m	m	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	59	j.co	j.co	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	60	m	m	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	61	/	/	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	62	B	B	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	63	M	M	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	64	J	J	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	65	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	66	first	first	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	67	p	p	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	68	u	u	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	69	b	b	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	70	lish	lish	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	71	e	e	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	72	d	d	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	73	a	a	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	74	s	s	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	75	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	76	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	77	.1	.1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	78	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	79	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	80	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	81	/b	/b	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	82	m	m	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	83	j.3	j.3	$
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	84	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	85	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	86	.6	.6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	87	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	88	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	89	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	90	.9	.9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	91	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	92	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	93	o	o	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	94	n	n	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	95	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	96	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	97	A	A	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	98	p	p	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	99	ril	ril	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	100	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	101	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	102	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	103	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	154	104	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	1	D	D	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	2	o	o	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	3	w	w	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	4	n	n	XX
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	5	lo	lo	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	6	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	7	d	d	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	8	e	e	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	9	d	d	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	10	fro	fro	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	11	m	m	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	12	http://www.bmj.com/	http://www.bmj.com/	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	13	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	14	baseline	baseline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	15	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	16	seen	see	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	17	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	18	35	35	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	19	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	20	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	21	38	38	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	22	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	23	receiving	receive	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	24	oxypentifylline	oxypentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	25	compared	compare	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	26	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	27	26	26	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	28	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	29	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	30	42	42	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	31	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	32	receiving	receive	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	33	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	34	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	35	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	36	X2=	X2=	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	37	10	10	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	38	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	39	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	40	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	41	p=0O002	p=0O002	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	42	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	155	43	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	156	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	156	2	tolerability	tolerability	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	156	3	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	156	4	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	156	5	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	156	6	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	156	7	studied	study	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	156	8	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	1	Un-	Un-	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	2	wanted	wanted	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	3	effects	effect	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	4	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	5	comparable	comparable	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	6	between	between	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	7	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	8	two	two	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	9	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	10	groups	group	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	11	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	12	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	13	17	17	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	14	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	15	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	16	38	38	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	17	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	18	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	19	45	45	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	20	%	%	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	21	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	22	who	who	WP
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	23	received	receive	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	24	oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	25	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	26	14	14	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	27	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	28	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	29	42	42	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	30	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	31	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	32	33	33	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	33	%	%	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	34	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	35	who	who	WP
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	36	received	receive	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	37	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	38	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	39	complaining	complain	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	40	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	41	side	side	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	42	effects	effect	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	43	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	44	X2l	x2l	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	45	=	=	NFP
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	46	I	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	47	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	48	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	49	p=0	p=0	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	50	30	30	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	51	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	157	52	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	1	There	there	EX
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	2	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	3	an	an	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	4	excess	excess	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	5	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	6	drop	drop	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	7	outs	out	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	8	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	9	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	10	group	group	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	11	treated	treat	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	12	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	13	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	14	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	15	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	16	9/42	9/42	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	17	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	18	21	21	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	19	%	%	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	20	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	21	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	22	com-	com-	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	23	pared	pare	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	24	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	25	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	26	group	group	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	27	treated	treat	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	28	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	29	oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	30	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	31	3/38	3/38	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	32	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	33	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	34	%	%	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	35	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	36	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	37	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	38	but	but	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	39	this	this	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	40	difference	difference	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	41	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	42	not	not	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	43	significant	significant	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	44	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	45	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	46	=	=	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	47	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	48	-9	-9	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	49	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	50	p=009	p=009	ADD
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	51	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	158	52	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	1	Most	Most	JJS
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	2	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	3	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	4	drop	drop	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	5	outs	out	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	6	occurred	occur	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	7	early	early	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	8	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	9	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	10	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	11	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	12	but	but	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	13	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	14	only	only	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	15	one	one	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	16	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	17	these	these	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	18	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	19	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	20	there	there	EX
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	21	evidence	evidence	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	22	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	23	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	24	reduction	reduction	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	25	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	26	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	27	area	area	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	28	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	29	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	30	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	159	31	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	160	1	This	this	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	160	2	particular	particular	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	160	3	patient	patient	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	160	4	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	160	5	receiving	receive	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	160	6	oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	160	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	2	three	three	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	3	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	4	taking	take	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	5	oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	6	who	who	WP
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	7	withdrew	withdraw	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	8	from	from	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	9	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	10	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	11	did	do	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	12	so	so	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	13	because	because	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	14	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	15	oedema	oedema	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	16	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	17	depres-	depres-	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	18	sion	sion	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	19	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	20	vomiting	vomiting	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	21	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	22	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	23	dyspepsia	dyspepsia	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	24	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	25	diarrhoea	diarrhoea	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	161	26	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	1	Seven	seven	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	2	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	3	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	4	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	5	taking	take	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	6	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	7	withdrew	withdraw	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	8	because	because	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	9	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	10	purpura	purpura	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	11	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	12	skin	skin	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	13	rash	rash	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	14	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	15	dizziness	dizziness	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	16	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	17	diarrhoea	diarrhoea	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	18	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	19	two	two	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	20	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	21	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	22	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	23	cellulitis	cellulitis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	24	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	25	pain	pain	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	26	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	27	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	28	headache	headache	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	29	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	30	nausea	nausea	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	31	;	;	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	32	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	33	two	two	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	34	others	other	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	35	dropped	drop	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	36	out	out	RP
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	37	because	because	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	38	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	39	poor	poor	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	40	compliance	compliance	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	41	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	42	because	because	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	43	an	an	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	44	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	45	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	46	diagnosed	diagnose	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	47	as	as	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	48	pemphigoid	pemphigoid	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	162	49	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	163	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	163	2	unwanted	unwanted	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	163	3	effects	effect	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	163	4	described	describe	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	163	5	are	be	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	163	6	listed	list	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	163	7	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	163	8	table	table	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	163	9	II	II	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	163	10	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	164	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	164	2	rABLE	rable	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	164	3	II-	II-	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	164	4	Unwanted	unwanted	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	164	5	effects	effect	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	164	6	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	164	7	oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	164	8	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	164	9	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	164	10	classified	classify	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	164	11	b	b	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	164	12	type	type	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	164	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	1	Values	value	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	2	are	be	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	3	numbers	number	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	4	ofcomplaints	ofcomplaint	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	5	Type	type	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	6	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	7	complaint	complaint	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	8	Oxpentifvlline	Oxpentifvlline	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	9	Placebo	Placebo	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	10	System	System	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	11	affected	affect	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	12	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	13	Central	central	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	14	nervous	nervous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	15	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	16	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	17	Respiratory	Respiratory	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	18	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	19	Cardiovascular	Cardiovascular	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	20	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	21	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	22	Gastrointestinal	Gastrointestinal	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	23	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	24	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	25	Genitourinary	Genitourinary	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	26	I	I	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	27	Skin	skin	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	28	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	29	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	30	Infection	infection	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	31	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	32	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	33	Pain	Pain	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	34	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	35	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	36	Unspecified	Unspecified	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	37	I	I	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	38	Total	total	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	39	26	26	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	40	22	22	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	41	discrepancy	discrepancy	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	42	between	between	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	43	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	44	incidence	incidence	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	45	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	46	adverse	adverse	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	47	events	event	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	48	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	49	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	50	incidence	incidence	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	51	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	52	drop	drop	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	53	out	out	RP
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	54	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	55	each	each	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	56	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	57	group	group	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	58	suggests	suggest	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	59	that	that	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	60	other	other	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	61	factors	factor	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	62	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	63	such	such	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	64	as	as	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	65	failure	failure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	66	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	67	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	68	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	69	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	70	respond	respond	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	71	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	72	rather	rather	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	73	than	than	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	74	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	75	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	76	itself	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	77	might	may	MD
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	78	have	have	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	79	been	be	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	80	responsible	responsible	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	81	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	82	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	83	dropping	drop	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	84	out	out	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	85	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	86	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	87	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	165	88	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	1	Possible	possible	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	2	confounding	confound	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	3	factors	factor	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	4	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	5	studied	study	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	6	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	7	see	see	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	8	whether	whether	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	9	these	these	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	10	had	have	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	11	any	any	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	12	effect	effect	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	13	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	14	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	15	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	16	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	17	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	166	18	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	2	dressing	dress	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	3	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	4	bandaging	bandage	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	5	methods	method	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	6	used	use	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	7	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	8	com-	com-	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	9	pared	pare	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	10	between	between	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	11	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	12	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	13	groups	group	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	14	but	but	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	15	no	no	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	16	differences	difference	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	17	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	18	found	find	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	167	19	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	2	effects	effect	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	3	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	4	centre	centre	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	5	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	6	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	7	size	size	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	8	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	9	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	10	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	11	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	12	baseline	baseline	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	13	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	14	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	15	length	length	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	16	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	17	history	history	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	18	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	19	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	20	disease	disease	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	21	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	22	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	23	duration	duration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	24	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	25	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	26	current	current	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	27	episode	episode	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	28	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	29	disease	disease	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	30	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	31	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	32	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	33	type	type	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	34	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	35	conservative	conservative	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	36	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	37	used	use	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	38	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	39	all	all	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	40	studied	study	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	41	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	42	possible	possible	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	43	interactions	interaction	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	44	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	45	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	168	46	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	169	1	No	no	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	169	2	such	such	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	169	3	inter-	inter-	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	169	4	actions	action	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	169	5	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	169	6	detected	detect	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	169	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	1	Discussion	discussion	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	2	We	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	3	have	have	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	4	confirmed	confirm	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	5	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	6	report	report	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	7	that	that	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	8	oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	9	might	may	MD
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	10	be	be	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	11	effective	effective	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	12	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	13	healing	heal	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	14	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	15	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	16	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	17	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	18	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	19	when	when	WRB
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	20	added	add	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	21	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	22	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	23	regimen	regimen	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	24	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	25	compression	compression	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	26	bandaging	bandage	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	170	27	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	1	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	2	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	3	effect	effect	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	4	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	5	different	different	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	6	dressings	dressing	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	7	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	8	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	9	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	10	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	11	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	12	has	have	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	13	been	be	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	14	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	15	subject	subject	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	16	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	17	extensive	extensive	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	18	research	research	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	19	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	20	but	but	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	21	few	few	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	22	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	23	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	24	studies	study	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	25	have	have	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	26	been	be	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	27	properly	properly	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	28	controlled	control	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	171	29	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	1	A	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	2	review	review	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	3	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	4	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	5	subject	subject	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	6	found	find	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	7	little	little	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	8	evidence	evidence	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	9	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	10	show	show	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	11	that	that	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	12	particular	particular	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	13	dressings	dressing	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	14	made	make	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	15	any	any	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	16	difference	difference	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	17	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	18	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	19	rates	rate	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	20	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	172	21	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	1	High	high	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	2	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	3	rates	rate	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	4	have	have	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	5	recently	recently	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	6	been	be	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	7	reported	report	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	8	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	9	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	10	four	four	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	11	layer	layer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	12	compression	compression	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	13	bandaging	bandage	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	14	method	method	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	15	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	16	its	-PRON-	PRP$
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	17	own	own	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	18	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	19	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	20	but	but	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	21	this	this	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	22	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	23	had	have	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	24	an	an	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	25	unusual	unusual	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	26	design	design	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	27	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	28	used	use	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	29	historical	historical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	30	controls	control	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	173	31	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	2	value	value	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	3	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	4	adequate	adequate	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	5	two	two	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	6	layer	layer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	7	compression	compression	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	8	bandaging	bandage	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	9	is	be	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	10	well	well	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	11	established.1'3	established.1'3	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	12	Although	although	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	13	pharmacological	pharmacological	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	14	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	15	has	have	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	16	been	be	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	17	advo-	advo-	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	18	cated	cat	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	19	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	20	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	21	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	22	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	23	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	24	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	25	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	26	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	27	few	few	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	28	studies	study	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	29	*	*	NFP
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	30	Oxpentifylline	Oxpentifylline	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	31	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	32	n=38	n=38	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	33	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	34	o	o	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	35	Placebo	Placebo	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	36	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	37	n=42	n=42	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	38	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	39	10-	10-	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	40	Q-	Q-	NNPS
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	41	640-T	640-t	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	42	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	43	T	t	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	44	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	45	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	46	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	47	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	48	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	49	10	10	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	50	12	12	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	51	14	14	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	52	1'6	1'6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	53	18	18	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	54	20	20	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	55	22	22	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	56	24	24	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	57	Time	time	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	58	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	59	weeks	week	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	60	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	61	FIG	FIG	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	62	2-	2-	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	63	Ulcer	Ulcer	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	64	area	area	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	65	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	66	each	each	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	67	visi't	visi't	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	174	68	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	1	Values	value	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	2	are	be	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	3	medians	median	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	4	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	5	950o	950o	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	6	confidence	confidence	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	7	intervals	interval	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	8	that	that	WDT
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	9	have	have	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	10	been	be	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	11	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	12	controlled	control	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	13	have	have	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	14	had	have	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	15	design	design	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	16	problems	problem	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	175	17	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	1	Their	-PRON-	PRP$
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	2	shortcomings	shortcoming	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	3	have	have	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	4	included	include	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	5	inade-	inade-	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	6	quate	quate	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	7	numbers	number	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	8	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	9	patients,'92	patients,'92	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	10	'	'	POS
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	11	crossover	crossover	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	12	design,0	design,0	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	13	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	14	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	15	end	end	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	16	points	point	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	17	other	other	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	18	than	than	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	19	complete	complete	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	20	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	21	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	22	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	23	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	24	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	176	25	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	1	19120	19120	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	2	A	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	3	well	well	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	4	designed	design	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	5	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	6	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	7	rutosides	rutoside	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	8	showed	show	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	9	no	no	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	10	effect	effect	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	11	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	12	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	13	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	14	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	15	ulcers.2	ulcers.2	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	16	Two	two	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	17	studies	study	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	18	using	use	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	19	profibrinolytic	profibrinolytic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	20	agents	agent	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	21	have	have	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	22	yielded	yield	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	23	conflicting	conflicting	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	24	results	result	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	177	25	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	1	A	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	2	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	3	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	4	defibrotide	defibrotide	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	5	showed	show	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	6	some	some	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	7	effect	effect	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	8	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	9	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	10	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	11	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	12	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	13	but	but	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	14	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	15	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	16	crossover	crossover	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	17	design,2	design,2	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	18	whereas	whereas	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	19	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	20	large	large	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	21	controlled	control	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	22	trial	trial	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	23	found	find	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	24	that	that	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	25	stanozolol	stanozolol	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	26	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	27	ineffective	ineffective	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	28	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	29	promoting	promote	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	30	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	31	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	32	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	33	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	34	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	35	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	36	A	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	37	D	d	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	38	R	R	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	39	Northeast	Northeast	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	40	et	et	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	41	al	al	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	42	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	43	venous	venous	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	44	forum	forum	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	45	meeting	meeting	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	46	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	47	Manchester	Manchester	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	48	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	49	1989	1989	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	50	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	178	51	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	1	Studies	study	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	2	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	3	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	4	bacteriology	bacteriology	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	5	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	6	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	7	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	8	suggest	suggest	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	9	that	that	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	10	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	11	role	role	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	12	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	13	antibiotics	antibiotic	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	14	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	15	anti-	anti-	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	16	septics	septic	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	17	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	18	promoting	promote	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	19	healing	healing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	20	is	be	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	21	limited	limited	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	22	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	23	those	those	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	24	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	25	frank	frank	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	26	infection.2	infection.2	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	27	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	28	haemorrheological	haemorrheological	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	29	properties	property	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	30	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	31	oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	32	have	have	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	33	been	be	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	34	widely	widely	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	35	studied	study	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	36	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	37	described.2	described.2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	38	Of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	39	parti-	parti-	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	40	cular	cular	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	41	interest	interest	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	42	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	43	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	44	context	context	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	45	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	46	our	-PRON-	PRP$
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	47	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	48	are	be	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	49	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	50	properties	property	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	51	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	52	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	53	compound	compound	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	54	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	55	regard	regard	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	56	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	57	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	58	patho-	patho-	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	59	physiology	physiology	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	60	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	61	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	62	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	179	63	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	1	Oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	2	improves	improve	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	3	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	4	delivery	delivery	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	5	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	6	oxygen	oxygen	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	7	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	8	ischaemic	ischaemic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	9	tissues,2	tissues,2	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	10	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	11	has	have	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	12	fibrinolytic	fibrinolytic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	13	effects26	effects26	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	14	that	that	WDT
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	15	are	be	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	16	possibly	possibly	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	17	mediated	mediate	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	18	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	19	leucocytes,2	leucocytes,2	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	20	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	21	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	22	reduces	reduce	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	23	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	24	adhesion	adhesion	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	25	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	26	polymorpho-	polymorpho-	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	27	nuclear	nuclear	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	28	leucocytes.2	leucocytes.2	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	29	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	30	These	these	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	31	properties	property	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	32	might	may	MD
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	33	explain	explain	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	34	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	35	clinical	clinical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	36	benefit	benefit	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	37	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	38	oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	39	seen	see	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	40	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	41	our	-PRON-	PRP$
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	42	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	180	43	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	1	We	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	2	conclude	conclude	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	3	that	that	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	4	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	5	healing	heal	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	6	rates	rate	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	7	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	8	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	9	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	10	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	11	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	12	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	13	will	will	MD
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	14	be	be	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	15	increased	increase	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	16	appreciably	appreciably	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	17	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	18	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	19	addition	addition	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	20	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	21	oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	22	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	23	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	24	standard	standard	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	25	regimen	regimen	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	26	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	27	dressing	dressing	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	28	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	29	compression	compression	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	30	bandaging	bandage	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	181	31	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	2	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	3	nurses	nurse	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	4	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	5	technicians	technician	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	6	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	7	Mrs	Mrs	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	8	J	J	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	9	Moller	Moller	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	10	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	11	London	London	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	12	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	13	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	14	Mrs	Mrs	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	15	T	T	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	16	Kelly	Kelly	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	17	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	18	London	London	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	19	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	20	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	21	Mr	Mr	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	22	D	D	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	23	Metoo	Metoo	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	24	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	25	Rochdale	Rochdale	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	26	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	27	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	28	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	29	Mr	Mr	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	30	S	S	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	31	Stanley	Stanley	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	32	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	33	Dublin	Dublin	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	34	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	182	35	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	1	We	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	2	acknowledge	acknowledge	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	3	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	4	advice	advice	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	5	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	6	help	help	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	7	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	8	Drs	Drs	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	9	S	S	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	10	Allen	Allen	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	11	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	12	M	M	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	13	Sugrue	Sugrue	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	14	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	15	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	16	administrative	administrative	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	17	support	support	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	18	provided	provide	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	19	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	20	Hoechst	Hoechst	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	21	UK	UK	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	22	Limited	Limited	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	183	23	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	184	1	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	184	2	Callam	Callam	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	184	3	MJ	MJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	184	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	184	5	Ruckley	Ruckley	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	184	6	CV	CV	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	184	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	184	8	Harper	Harper	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	184	9	DR	DR	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	184	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	184	11	Dale	Dale	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	184	12	JJ	JJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	184	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	185	1	Chronic	chronic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	185	2	ulceration	ulceration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	185	3	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	185	4	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	185	5	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	185	6	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	185	7	extent	extent	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	185	8	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	185	9	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	185	10	problem	problem	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	185	11	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	185	12	provision	provision	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	185	13	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	185	14	care	care	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	185	15	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	186	1	BrMedJ	BrMedJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	186	2	1985;290:1855	1985;290:1855	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	186	3	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	186	4	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	186	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	187	1	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	187	2	Harkiss	Harkiss	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	187	3	KJ	KJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	187	4	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	188	1	Cost	cost	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	188	2	analysis	analysis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	188	3	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	188	4	dressing	dress	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	188	5	materials	material	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	188	6	used	use	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	188	7	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	188	8	venotus	venotus	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	188	9	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	188	10	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	188	11	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	189	1	PharmacvJ3ournal	PharmacvJ3ournal	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	189	2	1985;235:268	1985;235:268	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	189	3	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	189	4	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	189	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	190	1	3	3	LS
work_dkfzaqe2ezbwvieo2gzsrnlssu	190	2	Browse	Browse	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	190	3	NL	NL	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	190	4	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	191	1	Venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	191	2	ulceration	ulceration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	191	3	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	192	1	Br	br	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	192	2	MedJ	MedJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	192	3	1983;286:1920	1983;286:1920	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	192	4	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	192	5	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	192	6	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	193	1	4	4	LS
work_dkfzaqe2ezbwvieo2gzsrnlssu	193	2	Hobbs	Hobbs	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	193	3	JT	JT	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	193	4	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	194	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	194	2	post	post	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	194	3	thrombotic	thrombotic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	194	4	syndrome	syndrome	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	194	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	195	1	Scott	Scott	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	195	2	Medj	Medj	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	195	3	1978;23:323	1978;23:323	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	195	4	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	195	5	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	195	6	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	196	1	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	196	2	Browse	Browse	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	196	3	NL	NL	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	196	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	196	5	Burnand	Burnand	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	196	6	KG	KG	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	196	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	197	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	197	2	cause	cause	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	197	3	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	197	4	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	197	5	tulceration	tulceration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	197	6	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	198	1	Lancet	Lancet	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	198	2	1982;ii	1982;ii	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	198	3	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	198	4	243	243	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	198	5	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	198	6	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	198	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	199	1	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	199	2	Burnand	Burnand	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	199	3	KG	KG	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	199	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	199	5	Whimster	Whimster	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	199	6	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	199	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	199	8	Naidoo	Naidoo	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	199	9	A	A	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	199	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	199	11	Browse	Browse	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	199	12	NL	NL	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	199	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	1	Pericapillary	pericapillary	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	2	fibrin	fibrin	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	3	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	4	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	5	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	6	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	7	bearing	bear	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	8	skin	skin	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	9	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	10	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	11	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	12	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	13	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	14	cause	cause	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	15	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	16	lipodermatosclerosis	lipodermatosclerosis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	17	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	18	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	19	ulceration	ulceration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	200	20	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	201	1	Br	br	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	201	2	MedJ	MedJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	201	3	1982;285:1071	1982;285:1071	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	201	4	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	201	5	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	201	6	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	202	1	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	202	2	Coleridge	Coleridge	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	202	3	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	202	4	Smith	Smith	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	202	5	PD	PD	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	202	6	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	202	7	Thomas	Thomas	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	202	8	P	P	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	202	9	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	202	10	Scurr	Scurr	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	202	11	JH	JH	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	202	12	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	202	13	Dormandy	Dormandy	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	202	14	JA	JA	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	202	15	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	203	1	Causes	cause	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	203	2	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	203	3	s'enous	s'enous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	203	4	ulceration	ulceration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	203	5	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	203	6	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	203	7	new	new	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	203	8	hypothesis	hypothesis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	203	9	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	204	1	BrMedj	BrMedj	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	204	2	1988;296:1726	1988;296:1726	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	204	3	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	204	4	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	204	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	205	1	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	205	2	Thomas	Thomas	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	205	3	PRS	PRS	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	205	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	205	5	Nash	Nash	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	205	6	GB	GB	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	205	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	205	8	Dormandy	Dormandy	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	205	9	JA	JA	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	205	10	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	1	White	white	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	2	cell	cell	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	3	accumulation	accumulation	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	4	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	5	dependent	dependent	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	6	legs	leg	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	7	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	8	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	9	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	10	senous	senous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	11	hypertension	hypertension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	12	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	13	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	14	possible	possible	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	15	mechanism	mechanism	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	16	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	17	trophic	trophic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	18	changes	change	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	19	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	20	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	21	skin	skin	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	206	22	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	207	1	BrMedj	BrMedj	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	207	2	1988;296:1693	1988;296:1693	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	207	3	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	207	4	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	207	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	208	1	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	208	2	Jarrett	Jarrett	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	208	3	PEM	PEM	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	208	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	208	5	Moreland	Moreland	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	208	6	M	M	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	208	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	208	8	Browse	Browse	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	208	9	NL	NL	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	208	10	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	2	effect	effect	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	3	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	4	oxpentifylline	oxpentifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	5	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	6	'	'	``
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	7	Trental	Trental	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	8	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	9	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	10	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	11	fibrinolvtic	fibrinolvtic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	12	activity	activity	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	13	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	14	plasma	plasma	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	15	fibrinogen	fibrinogen	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	16	levels	level	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	209	17	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	210	1	Curr	curr	UH
work_dkfzaqe2ezbwvieo2gzsrnlssu	210	2	Med	Med	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	210	3	Res	Res	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	210	4	Opin	Opin	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	210	5	1977;4:492	1977;4:492	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	210	6	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	210	7	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	210	8	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	211	1	10	10	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	211	2	Mlatrai	Mlatrai	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	211	3	A	A	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	211	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	211	5	Ernst	Ernst	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	211	6	E.	E.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	211	7	Pentoxifylline	Pentoxifylline	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	211	8	improves	improve	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	211	9	white	white	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	211	10	cell	cell	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	211	11	rheology	rheology	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	211	12	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	211	13	claudicants	claudicant	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	211	14	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	212	1	Clintcal	Clintcal	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	212	2	Hemorrheology	Hemorrheology	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	212	3	1985;5:483	1985;5:483	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	212	4	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	212	5	91	91	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	212	6	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	213	1	11	11	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	213	2	Anonymous	Anonymous	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	213	3	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	214	1	ABPI	ABPI	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	214	2	data	data	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	214	3	sheet	sheet	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	214	4	compendium	compendium	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	214	5	1986	1986	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	214	6	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	214	7	87	87	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	214	8	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	214	9	london	london	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	214	10	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	214	11	Datapharm	Datapharm	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	214	12	Publications	Publications	NNPS
work_dkfzaqe2ezbwvieo2gzsrnlssu	214	13	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	214	14	1986	1986	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	214	15	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	215	1	12	12	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	215	2	Allen	Allen	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	215	3	S.	S.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	215	4	A	A	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	215	5	simple	simple	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	215	6	technique	technique	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	215	7	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	215	8	recording	record	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	215	9	varicose	varicose	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	215	10	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	215	11	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	216	1	Praclitioner	Praclitioner	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	216	2	1967;199:97	1967;199:97	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	216	3	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	216	4	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	216	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	217	1	13	13	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	217	2	Tennant	Tennant	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	217	3	WG	WG	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	217	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	217	5	Park	Park	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	217	6	KGM	KGM	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	217	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	217	8	Rucklcy	Rucklcy	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	217	9	CV	CV	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	217	10	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	218	1	Testing	test	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	218	2	compression	compression	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	218	3	bandages	bandage	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	218	4	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	219	1	Phlebology	phlebology	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	219	2	1988;3:55	1988;3:55	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	219	3	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	219	4	61	61	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	219	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	220	1	14	14	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	220	2	Armitage	Armitage	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	220	3	P	P	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	220	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	220	5	Berry	Berry	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	220	6	G.	G.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	220	7	Statistical	Statistical	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	220	8	methods	method	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	220	9	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	220	10	medical	medical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	220	11	research	research	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	220	12	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	221	1	Oxford	oxford	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	221	2	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	221	3	Blackwell	Blackwell	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	221	4	Scientific	Scientific	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	221	5	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	221	6	1987	1987	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	221	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	222	1	15	15	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	222	2	Callam	Callam	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	222	3	MJ	MJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	222	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	222	5	Harper	Harper	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	222	6	DR	DR	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	222	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	222	8	Dale	Dale	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	222	9	JJ	JJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	222	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	222	11	Ruckley	Ruckley	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	222	12	CV	CV	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	222	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	223	1	Chronic	chronic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	223	2	ulcer	ulcer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	223	3	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	223	4	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	223	5	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	223	6	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	223	7	clinical	clinical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	223	8	history	history	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	223	9	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	224	1	Br	br	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	224	2	MedJ7	MedJ7	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	224	3	1987;294:1389	1987;294:1389	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	224	4	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	224	5	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	224	6	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	224	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	1	974	974	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	2	BMJ	BMJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	3	VOLUME	volume	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	4	300	300	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	5	14	14	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	6	APRIL	APRIL	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	7	1990	1990	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	8	o	o	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	9	n	n	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	10	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	11	A	a	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	12	p	p	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	13	ril	ril	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	14	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	15	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	16	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	17	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	18	b	b	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	19	y	y	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	20	g	g	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	21	u	u	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	22	e	e	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	23	st	st	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	24	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	25	P	P	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	26	ro	ro	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	27	te	te	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	28	cte	cte	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	29	d	d	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	30	b	b	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	31	y	y	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	32	co	co	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	33	p	p	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	34	yrig	yrig	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	35	h	h	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	36	t.	t.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	37	h	h	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	38	ttp	ttp	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	39	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	40	//w	//w	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	41	w	w	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	42	w	w	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	43	.b	.b	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	44	m	m	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	45	j.co	j.co	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	46	m	m	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	47	/	/	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	48	B	B	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	49	M	M	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	50	J	J	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	51	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	52	first	first	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	53	p	p	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	54	u	u	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	55	b	b	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	56	lish	lish	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	57	e	e	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	58	d	d	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	59	a	a	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	60	s	s	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	61	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	62	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	63	.1	.1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	64	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	65	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	66	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	67	/b	/b	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	68	m	m	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	69	j.3	j.3	$
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	70	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	71	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	72	.6	.6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	73	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	74	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	75	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	76	.9	.9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	77	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	78	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	79	o	o	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	80	n	n	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	81	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	82	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	83	A	A	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	84	p	p	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	85	ril	ril	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	86	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	87	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	88	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	89	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	225	90	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	1	D	D	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	2	o	o	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	3	w	w	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	4	n	n	XX
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	5	lo	lo	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	6	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	7	d	d	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	8	e	e	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	9	d	d	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	10	fro	fro	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	11	m	m	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	12	http://www.bmj.com/	http://www.bmj.com/	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	13	16	16	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	14	W'eitgasscr	W'eitgasscr	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	15	H.	h.	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	16	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	17	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	18	uise	uise	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	19	ot	ot	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	20	'	'	``
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	21	pentoxilflline	pentoxilflline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	22	[	[	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	23	"	"	``
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	24	Frental	Frental	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	25	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	26	400	400	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	27	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	28	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	29	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	30	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	31	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	32	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	33	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	34	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	35	resuilts	resuilt	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	36	ol	old	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	37	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	38	dotuble	dotuble	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	39	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	40	blind	blind	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	41	trial	trial	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	226	42	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	227	1	I'liarrniaiherapeutica	I'liarrniaiherapeutica	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	227	2	1983;31sUppl	1983;31suppl	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	227	3	1:143	1:143	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	227	4	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	227	5	51	51	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	227	6	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	228	1	17	17	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	228	2	Anonymous	Anonymous	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	228	3	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	229	1	D)rcssings	d)rcssing	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	229	2	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	229	3	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	229	4	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	229	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	230	1	Drug	Drug	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	230	2	7The	7The	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	230	3	Bull	Bull	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	230	4	1986;24:9	1986;24:9	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	230	5	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	230	6	12	12	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	230	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	231	1	18	18	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	231	2	Blair	Blair	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	231	3	SD	SD	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	231	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	231	5	Wright	Wright	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	231	6	1)1)1	1)1)1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	231	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	231	8	Backhouse	Backhouse	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	231	9	CM	CM	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	231	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	231	11	Riddle	Riddle	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	231	12	E	E	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	231	13	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	231	14	MecCollum	MecCollum	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	231	15	CN	CN	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	231	16	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	232	1	Sustained	sustained	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	232	2	cotnpression	cotnpression	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	232	3	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	232	4	hcaling	hcaling	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	232	5	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	232	6	chronic	chronic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	232	7	vcnous	vcnous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	232	8	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	232	9	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	233	1	BrI	BrI	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	233	2	Mid	Mid	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	233	3	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	233	4	198X;297	198x;297	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	233	5	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	233	6	1159	1159	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	233	7	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	233	8	61	61	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	233	9	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	1	19	19	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	2	Arenas	arena	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	3	R	R	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	5	Atoche	Atoche	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	6	C.	C.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	7	I'ost	I'ost	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	8	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	9	thrombotic	thrombotic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	10	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	11	tilcers	tilcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	12	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	13	safety	safety	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	14	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	15	efficacy	efficacy	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	16	ot	ot	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	17	treat-	treat-	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	18	ment	ment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	19	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	20	pecltoxifylline	pecltoxifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	21	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	22	double	double	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	23	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	24	blind	blind	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	25	studv	studv	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	26	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	27	30	30	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	28	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	29	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	234	30	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	235	1	Dernatiologica	Dernatiologica	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	235	2	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	236	1	Revista	Revista	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	236	2	.exiciana	.exiciana	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	236	3	Se'gundia	Se'gundia	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	236	4	Eppoca	Eppoca	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	236	5	1988;32:34	1988;32:34	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	236	6	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	236	7	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	236	8	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	237	1	20	20	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	237	2	Levh	Levh	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	237	3	F.	F.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	237	4	Therapie	Therapie	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	237	5	des	des	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	237	6	Ulcus	Ulcus	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	237	7	cruris	cruri	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	237	8	venositm	venositm	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	237	9	mit	mit	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	237	10	Mauisedornextrakt	Mauisedornextrakt	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	237	11	und	und	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	237	12	Trimethvlhesperidinchalkon	Trimethvlhesperidinchalkon	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	237	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	238	1	Therapieevochi	Therapieevochi	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	238	2	1988;38:2325	1988;38:2325	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	238	3	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	238	4	31	31	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	238	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	1	21	21	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	2	Belcaro	Belcaro	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	3	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	5	Marelli	Marelli	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	6	C.	C.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	7	'	'	POS
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	8	reatment	reatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	9	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	10	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	11	lipodermatosclerosis	lipodermatosclerosis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	12	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	13	ulccration	ulccration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	14	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	15	venous	venous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	16	hypertetision	hypertetision	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	17	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	18	elastic	elastic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	19	compression	compression	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	20	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	21	fibrinolytic	fibrinolytic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	22	enhancement	enhancement	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	23	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	24	dcfibrotide	dcfibrotide	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	239	25	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	240	1	Phhiebolog	Phhiebolog	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	240	2	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	240	3	1989;4:91	1989;4:91	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	240	4	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	240	5	106	106	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	240	6	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	241	1	22	22	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	241	2	Mann	Mann	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	241	3	Rj	Rj	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	241	4	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	1	A	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	2	double	double	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	3	bliid	bliid	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	4	trial	trial	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	5	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	6	oral	oral	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	7	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	8	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	9	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	10	i	i	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	11	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	12	hNdroxtxeth\l	hNdroxtxeth\l	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	13	rtitosides	rtitoside	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	14	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	15	statis	statis	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	16	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	17	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	242	18	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	243	1	Br	br	UH
work_dkfzaqe2ezbwvieo2gzsrnlssu	243	2	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	243	3	Clin	Clin	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	243	4	Pract	Pract	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	243	5	198	198	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	243	6	1;35:79	1;35:79	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	243	7	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	243	8	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	243	9	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	243	10	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	244	1	23	23	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	244	2	Schraibman	Schraibman	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	244	3	IG	IG	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	244	4	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	245	1	'	'	``
work_dkfzaqe2ezbwvieo2gzsrnlssu	245	2	I'he	I'he	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	245	3	bacteriology	bacteriology	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	245	4	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	245	5	leg	leg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	245	6	ulcers	ulcer	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	245	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	246	1	Phlebologi	Phlebologi	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	246	2	'	'	POS
work_dkfzaqe2ezbwvieo2gzsrnlssu	246	3	1987;2:265	1987;2:265	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	246	4	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	246	5	70	70	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	246	6	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	247	1	24	24	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	247	2	Ward	Ward	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	247	3	A	A	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	247	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	247	5	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	247	6	lissold	lissold	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	247	7	SP	SP	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	247	8	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	248	1	Pentoxifvlline	pentoxifvlline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	248	2	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	248	3	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	248	4	review	review	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	248	5	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	248	6	its	-PRON-	PRP$
work_dkfzaqe2ezbwvieo2gzsrnlssu	248	7	pharmacodytiamic	pharmacodytiamic	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	248	8	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	248	9	pharmacokilnetic	pharmacokilnetic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	248	10	properties	property	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	248	11	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	248	12	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	248	13	its	-PRON-	PRP$
work_dkfzaqe2ezbwvieo2gzsrnlssu	248	14	thcrapeutic	thcrapeutic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	248	15	efficacy	efficacy	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	248	16	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	249	1	I)rugs	I)rugs	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	249	2	1987;34	1987;34	NNPS
work_dkfzaqe2ezbwvieo2gzsrnlssu	249	3	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	249	4	50	50	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	249	5	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	249	6	97	97	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	249	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	250	1	25	25	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	250	2	James	James	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	250	3	DR	DR	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	250	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	250	5	Holland	Holland	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	250	6	BM	BM	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	250	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	250	8	Hughes	Hughes	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	250	9	MR	MR	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	250	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	250	11	Joncs	Joncs	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	250	12	JG	JG	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	250	13	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	250	14	WXardrop	WXardrop	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	250	15	CAJ	CAJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	250	16	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	1	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	2	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	3	xpentri-	xpentri-	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	4	fvllinc	fvllinc	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	5	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	6	eftf'ects	eftf'ect	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	7	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	8	rcd	rcd	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	9	cell	cell	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	10	deformabilitv	deformabilitv	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	11	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	12	oxygen	oxygen	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	13	availability	availability	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	14	f'ront	f'ront	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	15	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	16	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	17	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	18	intcrmittcnt	intcrmittcnt	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	19	claudication	claudication	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	251	20	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	252	1	Clinical	Clinical	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	252	2	Hernorrlihcologv	Hernorrlihcologv	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	252	3	1984;4:525	1984;4:525	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	252	4	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	252	5	31	31	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	252	6	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	1	26	26	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	2	Angelkort	Angelkort	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	3	B	B	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	5	Kiesewetter	Kiesewetter	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	6	H.	H.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	7	Influence	Influence	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	8	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	9	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	10	risk	risk	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	11	factors	factor	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	12	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	13	coagulatioit	coagulatioit	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	14	phenomena	phenomenon	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	15	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	16	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	17	fluidity	fluidity	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	18	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	19	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	20	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	21	chronic	chronic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	22	arterial	arterial	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	23	occlusive	occlusive	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	24	discasc	discasc	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	253	25	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	254	1	ScandJ7	scandj7	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	254	2	Clin	Clin	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	254	3	Lab	Lab	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	254	4	Invest	Invest	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	254	5	1984;41(suppl	1984;41(suppl	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	254	6	156):185	156):185	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	254	7	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	254	8	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	254	9	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	1	27	27	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	2	Knox	Knox	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	3	P.	P.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	4	Leukoc\te	Leukoc\te	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	5	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	6	mediated	mediate	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	7	activation	activation	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	8	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	9	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	10	fibrinolvtic	fibrinolvtic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	11	pathw\ay	pathw\ay	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	12	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	13	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	14	effects	effect	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	15	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	16	pentoxifylline	pentoxifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	255	17	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	256	1	In	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	256	2	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	256	3	Mandell	Mandell	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	256	4	GL	GL	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	256	5	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	256	6	Novick	Novick	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	256	7	Wj	Wj	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	256	8	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	256	9	eds	eds	XX
work_dkfzaqe2ezbwvieo2gzsrnlssu	256	10	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	257	1	Pentoxifvlline	pentoxifvlline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	257	2	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	257	3	leukocyte	leukocyte	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	257	4	function	function	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	257	5	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	258	1	Somerville	Somerville	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	258	2	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	258	3	New	New	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	258	4	Jersey	Jersey	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	258	5	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	258	6	Hoechst	Hoechst	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	258	7	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	258	8	Roussel	Roussel	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	258	9	Pharmaceuticals	Pharmaceuticals	NNPS
work_dkfzaqe2ezbwvieo2gzsrnlssu	258	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	258	11	1988:96	1988:96	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	258	12	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	258	13	104	104	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	258	14	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	1	28	28	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	2	Bertocchi	Bertocchi	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	3	F	F	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	4	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	5	P'roserpio	P'roserpio	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	6	P	P	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	8	Lampugnani	Lampugnani	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	9	MG	MG	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	11	Detana	Detana	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	12	E.	E.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	13	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	14	ctt'ect	ctt'ect	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	15	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	16	pentoxifylline	pentoxifylline	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	17	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	18	polymorphonuclear	polymorphonuclear	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	19	cell	cell	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	20	adhesion	adhesion	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	21	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	22	cultured	cultured	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	23	endothelial	endothelial	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	24	cells	cell	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	259	25	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	260	1	A	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	260	2	preliminary	preliminary	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	260	3	report	report	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	260	4	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	261	1	In	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	261	2	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	261	3	Mandell	Mandell	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	261	4	GL	GL	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	261	5	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	261	6	Novick	Novick	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	261	7	WrJ	WrJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	261	8	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	261	9	eds	eds	XX
work_dkfzaqe2ezbwvieo2gzsrnlssu	261	10	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	262	1	Penioxifvl	Penioxifvl	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	262	2	/	/	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	262	3	inei	inei	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	262	4	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	262	5	leukoctiie	leukoctiie	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	262	6	function	function	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	262	7	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	263	1	Somerville	Somerville	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	263	2	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	263	3	New	New	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	263	4	Jersey	Jersey	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	263	5	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	263	6	Hoechst	Hoechst	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	263	7	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	263	8	Roussel	Roussel	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	263	9	Pharmaceuticals	Pharmaceuticals	NNPS
work_dkfzaqe2ezbwvieo2gzsrnlssu	263	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	263	11	1988:68	1988:68	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	263	12	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	263	13	74	74	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	263	14	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	1	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	2	Accepted	Accepted	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	3	15	15	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	4	7anuary	7anuary	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	5	1990	1990	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	6	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	7	Relation	relation	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	8	between	between	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	9	dose	dose	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	10	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	11	bendrofluazide	bendrofluazide	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	12	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	13	antihypertensive	antihypertensive	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	14	effect	effect	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	15	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	16	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	17	adverse	adverse	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	18	biochemical	biochemical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	19	effects	effect	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	20	Jan	Jan	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	21	E	E	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	22	Carlsen	Carlsen	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	23	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	24	Lars	Lars	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	25	K0ber	K0ber	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	26	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	27	Christian	Christian	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	28	Torp	Torp	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	29	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	30	Pedersen	Pedersen	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	31	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	32	Peter	Peter	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	33	Johansen	Johansen	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	34	Abstract	Abstract	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	35	Objective	Objective	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	36	-	-	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	37	To	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	38	determine	determine	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	39	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	40	relevant	relevant	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	41	dose	dose	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	42	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	43	bendrofluazide	bendrofluazide	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	44	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	45	treating	treat	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	46	mild	mild	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	47	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	48	moderate	moderate	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	49	hypertension	hypertension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	264	50	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	1	Design	design	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	2	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	3	Double	double	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	4	blind	blind	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	5	parallel	parallel	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	6	group	group	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	7	trial	trial	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	8	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	9	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	10	who	who	WP
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	11	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	12	given	give	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	13	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	14	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	15	six	six	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	16	weeks	week	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	17	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	18	then	then	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	19	randomly	randomly	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	20	allocated	allocate	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	21	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	22	various	various	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	23	doses	dose	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	24	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	25	bendro-	bendro-	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	26	fluazide	fluazide	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	27	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	28	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	29	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	30	25	25	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	31	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	32	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	33	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	34	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	35	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	36	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	37	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	38	10	10	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	39	mg	mg	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	40	daily	daily	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	41	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	42	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	43	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	44	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	45	12	12	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	46	weeks	week	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	265	47	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	266	1	Setting-	Setting-	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	266	2	General	General	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	266	3	practices	practice	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	266	4	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	266	5	Zealand	Zealand	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	266	6	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	266	7	Denmark	Denmark	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	266	8	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	1	Patients-257	patients-257	LS
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	2	Patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	3	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	4	newly	newly	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	5	diagnosed	diagnose	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	6	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	7	previously	previously	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	8	treated	treat	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	9	hypertension	hypertension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	11	aged	age	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	12	25	25	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	13	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	14	70	70	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	15	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	16	who	who	WP
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	17	had	have	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	18	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	19	mean	mean	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	20	diastolic	diastolic	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	21	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	22	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	23	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	24	100	100	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	25	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	26	120	120	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	27	mm	mm	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	28	Hg	Hg	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	29	after	after	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	30	receiving	receive	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	31	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	32	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	33	six	six	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	34	weeks	week	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	267	35	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	1	Main	main	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	2	outcome	outcome	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	3	measures	measure	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	4	-	-	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	5	Reduction	reduction	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	6	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	7	diastolic	diastolic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	8	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	9	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	10	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	11	changes	change	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	12	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	13	biochemical	biochemical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	14	variables	variable	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	15	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	16	potassium	potassium	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	17	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	18	urate	urate	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	19	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	20	glucose	glucose	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	21	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	22	fructosamine	fructosamine	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	23	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	24	total	total	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	25	cholesterol	cholesterol	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	26	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	27	apolipoprotein	apolipoprotein	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	28	A	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	29	I	i	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	30	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	31	apolipoprotein	apolipoprotein	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	32	B	b	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	33	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	34	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	35	triglyceride	triglyceride	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	36	concentrations	concentration	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	37	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	268	38	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	1	Results	result	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	2	-	-	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	3	All	all	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	4	doses	dose	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	5	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	6	bendrofluazide	bendrofluazide	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	7	significantly	significantly	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	8	reduced	reduce	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	9	diastolic	diastolic	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	10	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	11	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	12	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	13	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	14	same	same	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	15	degree	degree	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	16	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	17	10	10	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	18	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	19	11	11	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	20	mm	mm	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	21	Hg	Hg	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	22	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	269	23	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	1	Clear	clear	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	2	relations	relation	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	3	between	between	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	4	dose	dose	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	5	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	6	effect	effect	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	7	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	8	shown	show	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	9	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	10	potassium	potassium	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	11	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	12	urate	urate	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	13	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	14	glucose	glucose	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	15	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	16	total	total	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	17	cholesterol	cholesterol	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	18	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	19	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	20	apolipoprotein	apolipoprotein	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	21	B	B	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	22	concentra-	concentra-	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	23	tions	tion	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	270	24	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	2	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	3	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	4	25	25	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	5	mg	mg	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	6	dose	dose	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	7	increased	increase	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	8	only	only	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	9	urate	urate	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	10	con-	con-	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	11	centrations	centration	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	12	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	13	whereas	whereas	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	14	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	15	10	10	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	16	mg	mg	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	17	dose	dose	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	18	affected	affected	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	19	all	all	PDT
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	20	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	21	above	above	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	22	biochemical	biochemical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	23	variables	variable	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	271	24	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	1	Conclusion	conclusion	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	2	-	-	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	3	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	4	relevant	relevant	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	5	range	range	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	6	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	7	doses	dose	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	8	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	9	bendrofluazide	bendrofluazide	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	10	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	11	treat	treat	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	12	mild	mild	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	13	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	14	moderate	moderate	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	15	hyperten-	hyperten-	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	16	sion	sion	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	17	is	be	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	18	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	19	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	20	25	25	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	21	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	22	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	23	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	24	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	25	mg	mg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	26	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	27	day	day	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	272	28	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	273	1	Higher	high	JJR
work_dkfzaqe2ezbwvieo2gzsrnlssu	273	2	doses	dose	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	273	3	caused	cause	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	273	4	more	more	RBR
work_dkfzaqe2ezbwvieo2gzsrnlssu	273	5	pronounced	pronounced	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	273	6	adverse	adverse	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	273	7	biochemical	biochemical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	273	8	effects	effect	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	273	9	including	include	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	273	10	adverse	adverse	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	273	11	lipid	lipid	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	273	12	effects	effect	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	273	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	274	1	Previous	previous	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	274	2	trials	trial	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	274	3	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	274	4	bendro-	bendro-	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	274	5	fluazide	fluazide	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	274	6	have	have	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	274	7	used	use	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	274	8	too	too	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	274	9	high	high	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	274	10	doses	dose	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	274	11	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	275	1	Introduction	introduction	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	275	2	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	275	3	use	use	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	275	4	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	275	5	thiazides	thiazide	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	275	6	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	275	7	treating	treat	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	275	8	arterial	arterial	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	275	9	hypertension	hypertension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	275	10	has	have	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	275	11	been	be	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	275	12	criticised	criticise	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	275	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	2	arguments	argument	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	3	have	have	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	4	been	be	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	5	that	that	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	6	thiazides	thiazide	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	7	do	do	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	8	not	not	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	9	reduce	reduce	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	10	excess	excess	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	11	mortality	mortality	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	12	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	13	do	do	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	14	not	not	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	15	reduce	reduce	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	16	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	17	incidence	incidence	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	18	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	19	myocardial	myocardial	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	20	infarction	infarction	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	21	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	22	increase	increase	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	23	known	know	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	24	risk	risk	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	25	factors	factor	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	26	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	27	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	28	produce	produce	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	29	more	more	JJR
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	30	adverse	adverse	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	31	effects	effect	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	32	than	than	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	33	previously	previously	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	34	realised	realise	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	276	35	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	1	As	as	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	2	no	no	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	3	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	4	has	have	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	5	yet	yet	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	6	shown	show	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	7	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	8	clear	clear	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	9	reduction	reduction	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	10	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	11	mortality	mortality	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	12	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	13	morbidity	morbidity	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	14	from	from	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	15	acute	acute	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	16	myocardial	myocardial	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	17	infarction	infarction	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	18	interest	interest	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	19	has	have	VBZ
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	20	focused	focus	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	21	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	22	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	23	risk	risk	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	24	factors	factor	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	25	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	26	adverse	adverse	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	27	effects	effect	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	277	28	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	1	Evidence	evidence	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	2	against	against	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	3	thiazides	thiazide	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	4	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	5	substantiated	substantiate	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	6	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	7	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	8	Medical	Medical	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	9	Research	Research	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	10	Council	Council	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	11	trial	trial	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	12	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	13	which	which	WDT
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	14	compared	compare	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	15	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	16	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	17	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	18	fixed	fix	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	19	dose	dose	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	20	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	21	bendro-	bendro-	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	22	fluazide	fluazide	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	23	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	24	10	10	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	25	mg	mg	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	26	/	/	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	27	day	day	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	28	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	29	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	30	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	31	titrated	titrated	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	32	dose	dose	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	33	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	34	propranolol	propranolol	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	35	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	36	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	278	37	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	279	1	There	there	EX
work_dkfzaqe2ezbwvieo2gzsrnlssu	279	2	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	279	3	no	no	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	279	4	basis	basis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	279	5	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	279	6	choosing	choose	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	279	7	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	279	8	dose	dose	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	279	9	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	279	10	10	10	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	279	11	mg	mg	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	279	12	bendrofluazide	bendrofluazide	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	279	13	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	1	We	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	2	investigated	investigate	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	3	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	4	relevant	relevant	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	5	dose	dose	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	6	range	range	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	7	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	8	bendro-	bendro-	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	9	fluazide	fluazide	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	10	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	11	treating	treat	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	12	mild	mild	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	13	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	14	moderate	moderate	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	15	arterial	arterial	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	16	hyper-	hyper-	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	17	tension	tension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	18	as	as	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	19	this	this	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	20	could	could	MD
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	21	affect	affect	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	22	both	both	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	23	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	24	choice	choice	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	25	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	26	outcome	outcome	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	27	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	28	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	280	29	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	1	Methods	Methods	NNPS
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	2	Selection	Selection	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	3	ofpatients	ofpatient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	4	-	-	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	5	Patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	6	aged	age	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	7	25	25	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	8	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	9	70	70	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	10	presenting	present	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	11	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	12	general	general	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	13	practices	practice	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	14	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	15	Zealand	Zealand	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	16	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	17	Denmark	Denmark	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	18	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	19	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	20	newly	newly	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	21	diagnosed	diagnose	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	22	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	23	previously	previously	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	24	treated	treat	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	25	arterial	arterial	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	26	hypertension	hypertension	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	27	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	28	up	up	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	29	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	30	two	two	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	31	drugs	drug	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	32	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	33	who	who	WP
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	34	gave	give	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	35	informed	informed	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	36	consent	consent	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	37	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	38	eligible	eligible	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	39	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	40	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	41	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	281	42	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	1	Patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	2	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	3	excluded	exclude	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	4	if	if	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	5	they	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	6	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	7	pregnant	pregnant	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	8	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	9	lactating	lactating	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	10	;	;	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	11	had	have	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	12	had	have	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	13	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	14	myocardial	myocardial	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	15	infarction	infarction	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	16	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	17	stroke	stroke	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	18	within	within	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	19	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	20	past	past	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	21	six	six	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	22	months	month	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	23	;	;	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	24	had	have	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	25	angina	angina	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	26	pectoris	pectoris	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	27	;	;	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	28	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	29	being	be	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	30	treated	treat	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	31	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	32	heart	heart	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	33	failure	failure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	34	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	35	gout	gout	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	36	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	37	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	38	uncontrolled	uncontrolled	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	39	diabetes	diabetes	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	40	mellitus	mellitus	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	41	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	42	with	with	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	43	drugs	drug	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	44	that	that	WDT
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	45	reduced	reduce	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	46	lipid	lipid	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	47	concentrations	concentration	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	48	;	;	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	49	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	50	intolerant	intolerant	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	51	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	52	bendrofluazide	bendrofluazide	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	53	;	;	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	54	had	have	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	55	reduced	reduce	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	56	kidney	kidney	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	57	function	function	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	58	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	59	creatinine	creatinine	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	60	concentration	concentration	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	61	>	>	XX
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	62	150	150	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	63	[	[	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	64	tmol	tmol	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	65	/	/	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	66	l	l	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	67	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	68	;	;	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	69	did	do	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	70	not	not	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	71	take	take	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	72	80	80	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	73	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	74	120	120	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	75	%	%	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	76	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	77	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	78	prescribed	prescribed	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	79	tablets	tablet	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	80	while	while	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	81	receiving	receive	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	82	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	83	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	84	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	85	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	86	start	start	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	87	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	88	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	89	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	282	90	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	1	Study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	2	design	design	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	3	-	-	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	4	Patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	5	whose	whose	WP$
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	6	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	7	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	8	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	9	between	between	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	10	100	100	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	11	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	12	120	120	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	13	mm	mm	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	14	Hg	Hg	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	15	after	after	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	16	they	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	17	had	have	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	18	taken	take	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	19	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	20	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	21	six	six	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	22	weeks	week	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	23	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	24	randomly	randomly	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	25	allocated	allocate	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	26	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	27	blocks	block	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	28	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	29	10	10	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	30	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	31	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	32	double	double	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	33	blind	blind	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	34	basis	basis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	35	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	36	receive	receive	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	37	placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	38	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	39	bendrofluazide	bendrofluazide	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	40	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	41	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	42	dose	dose	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	43	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	44	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	45	25	25	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	46	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	47	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	48	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	49	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	50	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	51	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	52	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	53	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	54	10	10	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	55	mg	mg	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	56	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	57	day	day	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	283	58	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	284	1	Randomisation	randomisation	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	284	2	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	284	3	performed	perform	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	284	4	from	from	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	284	5	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	284	6	list	list	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	284	7	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	284	8	computer	computer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	284	9	generated	generate	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	284	10	numbers	number	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	284	11	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	2	10	10	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	3	mg	mg	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	4	dose	dose	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	5	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	6	chosen	choose	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	7	because	because	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	8	this	this	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	9	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	10	used	use	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	11	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	12	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	13	Medical	Medical	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	14	Research	Research	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	15	Council	Council	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	16	's	's	POS
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	17	trial	trial	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	18	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	19	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	20	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	21	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	22	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	23	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	24	mg	mg	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	25	doses	dose	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	26	because	because	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	27	they	-PRON-	PRP
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	28	are	be	VBP
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	29	recommended	recommend	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	30	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	31	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	32	joint	joint	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	33	national	national	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	34	committee	committee	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	35	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	36	detection	detection	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	37	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	38	evaluation	evaluation	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	39	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	40	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	41	treatment	treatment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	42	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	43	high	high	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	44	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	45	pressure	pressure	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	46	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	285	47	'	'	''
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	2	dose	dose	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	3	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	4	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	5	25	25	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	6	mg	mg	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	7	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	8	believed	believe	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	9	to	to	TO
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	10	represent	represent	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	11	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	12	point	point	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	13	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	14	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	15	lower	low	JJR
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	16	part	part	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	17	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	18	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	19	dose	dose	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	20	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	21	response	response	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	22	curve	curve	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	286	23	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	2	active	active	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	3	tablets	tablet	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	4	contained	contain	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	5	573	573	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	6	mg	mg	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	7	potassium	potassium	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	8	chloride	chloride	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	9	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	10	either	either	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	11	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	12	25	25	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	13	mg	mg	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	14	or	or	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	15	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	16	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	17	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	18	mg	mg	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	19	bendrofluazide	bendrofluazide	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	20	(	(	-LRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	21	Centyl	Centyl	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	22	K	K	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	23	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	24	Leo	Leo	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	25	Pharmaceutical	Pharmaceutical	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	26	Products	Products	NNPS
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	27	)	)	-RRB-
work_dkfzaqe2ezbwvieo2gzsrnlssu	287	28	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	288	1	Placebo	placebo	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	288	2	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	288	3	active	active	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	288	4	tablets	tablet	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	288	5	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	288	6	identical	identical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	288	7	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	288	8	appearance	appearance	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	288	9	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	288	10	taste	taste	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	288	11	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	289	1	All	all	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	289	2	patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	289	3	received	receive	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	289	4	four	four	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	289	5	tablets	tablet	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	289	6	daily	daily	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	289	7	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	289	8	two	two	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	289	9	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	289	10	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	289	11	morning	morning	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	289	12	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	289	13	two	two	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	289	14	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	289	15	lunch	lunch	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	289	16	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	1	Those	those	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	2	receiving	receive	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	3	fewer	few	JJR
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	4	than	than	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	5	four	four	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	6	active	active	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	7	tablets	tablet	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	8	daily	daily	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	9	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	10	given	give	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	11	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	12	active	active	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	13	tablets	tablet	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	14	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	15	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	16	morning	morning	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	290	17	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	1	Patients	patient	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	2	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	3	assessed	assess	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	4	on	on	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	5	an	an	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	6	outpatient	outpatient	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	7	basis	basis	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	8	for	for	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	9	four	four	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	10	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	11	10	10	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	12	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	13	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	14	12	12	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	15	weeks	week	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	16	after	after	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	17	randomisation	randomisation	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	291	18	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	1	Biochemical	biochemical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	2	variables	variable	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	3	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	4	measured	measure	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	5	before	before	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	6	ran-	ran-	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	7	domisation	domisation	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	8	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	9	at	at	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	10	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	11	end	end	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	12	of	of	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	13	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	14	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	15	;	;	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	16	these	these	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	17	variables	variable	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	18	included	include	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	19	total	total	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	20	cholesterol	cholesterol	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	21	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	22	apolipoprotein	apolipoprotein	VB
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	23	A	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	24	I	i	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	25	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	26	apolipoprotein	apolipoprotein	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	27	B	b	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	28	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	29	sodium	sodium	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	30	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	31	potassium	potassium	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	32	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	33	glucose	glucose	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	34	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	35	fructo-	fructo-	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	36	samine	samine	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	37	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	38	urate	urate	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	39	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	40	and	and	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	41	creatinine	creatinine	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	42	concentrations	concentration	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	292	43	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	293	1	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	293	2	study	study	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	293	3	was	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	293	4	approved	approve	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	293	5	by	by	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	293	6	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	293	7	local	local	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	293	8	ethical	ethical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	293	9	committee	committee	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	293	10	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	1	Methods	method	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	2	ofassessment	ofassessment	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	3	-	-	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	4	The	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	5	patient	patient	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	6	's	's	POS
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	7	blood	blood	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	8	pressures	pressure	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	9	were	be	VBD
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	10	measured	measure	VBN
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	11	twice	twice	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	12	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	13	in	in	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	14	the	the	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	15	sitting	sit	VBG
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	16	position	position	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	17	after	after	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	18	five	five	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	19	Medicon	Medicon	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	20	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	21	Svanem0llevej	svanem0llevej	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	22	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	23	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	24	DK-2100	DK-2100	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	25	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	26	K0benhavn	K0benhavn	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	27	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	28	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	29	Denmark	Denmark	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	30	Jan	Jan	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	31	E	E	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	32	Carlsen	Carlsen	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	33	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	34	MD	MD	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	35	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	36	senior	senior	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	37	lecturer	lecturer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	38	Lars	Lars	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	39	Kober	Kober	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	40	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	41	MD	MD	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	42	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	43	resident	resident	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	44	Christian	Christian	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	45	Torp	Torp	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	46	-	-	HYPH
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	47	Pedersen	Pedersen	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	48	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	49	MD	MD	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	50	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	51	senior	senior	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	52	lecturer	lecturer	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	53	Leo	Leo	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	54	Pharmaceutical	Pharmaceutical	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	55	Products	Products	NNPS
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	56	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	57	Industriparken	Industriparken	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	58	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	59	DK-2750	DK-2750	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	60	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	61	Ballerup	Ballerup	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	62	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	63	Denmark	Denmark	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	64	Peter	Peter	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	65	Johansen	Johansen	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	66	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	67	PHD	PHD	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	68	,	,	,
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	69	medical	medical	JJ
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	70	adviser	adviser	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	71	Correspondence	Correspondence	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	72	to	to	IN
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	73	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	74	Dr	Dr	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	75	Carisen	Carisen	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	294	76	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	1	BrMed7	BrMed7	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	2	1990;300:975	1990;300:975	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	3	-	-	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	4	8	8	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	5	BMJ	BMJ	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	6	VOLUME	volume	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	7	300	300	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	8	14	14	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	9	APRIL	APRIL	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	10	1990	1990	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	11	975	975	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	12	o	o	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	13	n	n	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	14	5	5	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	15	A	a	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	16	p	p	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	17	ril	ril	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	18	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	19	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	20	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	21	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	22	b	b	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	23	y	y	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	24	g	g	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	25	u	u	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	26	e	e	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	27	st	st	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	28	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	29	P	P	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	30	ro	ro	CC
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	31	te	te	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	32	cte	cte	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	33	d	d	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	34	b	b	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	35	y	y	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	36	co	co	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	37	p	p	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	38	yrig	yrig	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	39	h	h	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	40	t.	t.	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	41	h	h	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	42	ttp	ttp	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	43	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	44	//w	//w	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	45	w	w	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	46	w	w	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	47	.b	.b	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	48	m	m	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	49	j.co	j.co	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	50	m	m	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	51	/	/	SYM
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	52	B	B	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	53	M	M	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	54	J	J	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	55	:	:	:
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	56	first	first	RB
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	57	p	p	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	58	u	u	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	59	b	b	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	60	lish	lish	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	61	e	e	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	62	d	d	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	63	a	a	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	64	s	s	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	65	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	66	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	67	.1	.1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	68	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	69	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	70	6	6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	71	/b	/b	NNS
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	72	m	m	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	73	j.3	j.3	$
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	74	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	75	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	76	.6	.6	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	77	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	78	3	3	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	79	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	80	.9	.9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	81	7	7	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	82	2	2	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	83	o	o	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	84	n	n	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	85	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	86	4	4	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	87	A	A	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	88	p	p	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	89	ril	ril	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	90	1	1	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	91	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	92	9	9	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	93	0	0	CD
work_dkfzaqe2ezbwvieo2gzsrnlssu	295	94	.	.	.
work_dkfzaqe2ezbwvieo2gzsrnlssu	296	1	D	D	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	296	2	o	o	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	296	3	w	w	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	296	4	n	n	XX
work_dkfzaqe2ezbwvieo2gzsrnlssu	296	5	lo	lo	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	296	6	a	a	DT
work_dkfzaqe2ezbwvieo2gzsrnlssu	296	7	d	d	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	296	8	e	e	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	296	9	d	d	NN
work_dkfzaqe2ezbwvieo2gzsrnlssu	296	10	fro	fro	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	296	11	m	m	NNP
work_dkfzaqe2ezbwvieo2gzsrnlssu	296	12	http://www.bmj.com/	http://www.bmj.com/	NNP